Benign Neonatal Seizures

Mendelian MONDO:0016027 Pathograph 22 Show in embeddings browser Epilepsy

Benign neonatal seizures, now termed self-limited (familial) neonatal epilepsy (SeL[F]NE), is an autosomal dominant focal epilepsy syndrome of the newborn. Seizures usually begin between two and eight days after term birth in an otherwise healthy infant and remit during the first six to 12 months. Heterozygous pathogenic variants in KCNQ2 are the most common molecular cause, with KCNQ3 variants accounting for a smaller subgroup. Kv7.2 and Kv7.3 form neuronal M channels; reduced M-current weakens the subthreshold potassium conductance that restrains repetitive firing. Development is usually normal, but the label "self-limited" does not imply zero later risk: some individuals with KCNQ2-related disease have seizures later in life. Markedly abnormal neonatal EEG background, abnormal neurologic examination, persistent drug-resistant seizures, and developmental impairment instead raise concern for KCNQ2-related developmental and epileptic encephalopathy (KCNQ2-DEE), the severe end of the KCNQ2 spectrum.

Ask OpenScientist

Ask a research question about Benign Neonatal Seizures. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Mappings
2
Definitions
1
Inheritance
6
Pathophys.
11
Phenotypes
3
Gaps
22
Pathograph
2
Genes
2
Medical Actions
2
Subtypes
3
Differentials
1
Datasets
1
Trials
3
Models
16
References
1
Deep Research
🏷

Classifications

Harrison's Part
NEUROLOGIC
🔗

Mappings

MONDO
MONDO:0016027 benign neonatal seizures
skos:exactMatch Orphanet ORPHA:1949: CONSISTENT
Orphanet ORPHA:1949 (self-limited neonatal epilepsy) lists MONDO:0016027 as an exact cross-reference.
📘

Definitions

2
Clinical boundary of self-limited familial neonatal epilepsy
Focal motor seizures begin after a seizure-free interval, typically at age two to eight days in an otherwise healthy term infant, and remit by six to 12 months with generally normal development. Tonic limb stiffening, migration during an event, apnea, and cyanosis are characteristic semiologies. Acute symptomatic neonatal seizures and KCNQ2-DEE must be excluded before assigning the self-limited syndrome.
CASE_DEFINITION Applies to the neonatal-onset self-limited syndrome, whether familial or de novo. Infantile-onset self-limited epilepsy and neonatal-onset developmental and epileptic encephalopathy are separate disease boundaries.
Show evidence (2 references)
PMID:20437616 SUPPORT Other
"KCNQ2-SLFNE is characterized by seizures that start in otherwise healthy infants between two and eight days after term birth and spontaneously disappear between the first and the sixth to 12th month of life."
GeneReviews supplies the characteristic onset, health status, and remission interval for the KCNQ2-related syndrome.
PMID:20437616 SUPPORT Other
"Seizures are characterized by sudden onset with prominent motor involvement, often accompanied by apnea and cyanosis; video EEG identifies seizures as focal onset with tonic stiffening of limb(s) and some migration during each seizure's evolution."
GeneReviews defines the characteristic focal motor and autonomic seizure semiology.
👪

Inheritance

1
Autosomal dominant HP:0000006
Self-limited familial neonatal epilepsy segregates in an autosomal dominant manner in multigenerational families with heterozygous KCNQ2 or KCNQ3 variants. Most KCNQ2-related self-limited cases inherit the variant from a parent; each child of a heterozygous affected individual has a 50% chance of inheriting it. Incomplete penetrance and de novo cases occur.
Autosomal dominant inheritance
Show evidence (3 references)
ORPHA:1949 SUPPORT Other
"Autosomal dominant"
Orphanet directly lists autosomal dominant inheritance for ORPHA:1949.
PMID:9425895 SUPPORT Human Clinical
"One type is benign familial neonatal convulsions (BFNC), a dominantly inherited disorder of newborns."
The original KCNQ2 discovery paper characterizes BFNC as a dominantly inherited disorder of newborns.
PMID:20437616 SUPPORT Other
"Each child of a heterozygous individual with KCNQ2-SLFNE has a 50% chance of inheriting the pathogenic variant."
GeneReviews provides the recurrence risk for an affected heterozygous parent.
◆

Subtypes

2
KCNQ2-related benign familial neonatal seizures MONDO:0007365
The more common molecular subtype, caused by heterozygous loss-of-function variants in KCNQ2 on chromosome 20q13.3. Distinct from the more severe KCNQ2-related developmental and epileptic encephalopathy (KCNQ2-DEE).
Show evidence (2 references)
PMID:9425895 SUPPORT Human Clinical
"We have identified a sub-microscopic deletion of chromosome 20q13.3 that co-segregates with seizures in a BFNC family."
Singh et al. 1998 maps the KCNQ2-BFNC locus to chromosome 20q13.3.
ORPHA:1949 SUPPORT Other
"KCNQ2 | potassium voltage-gated channel subfamily Q member 2 | hgnc:6296 | Disease-causing germline mutation(s) in"
Orphanet identifies KCNQ2 as a disease-causing gene for self-limited neonatal epilepsy.
KCNQ3-related benign familial neonatal seizures MONDO:0007366
The less common molecular subtype, caused by heterozygous variants in KCNQ3 on chromosome 8q24.
Show evidence (2 references)
PMID:9425900 SUPPORT Human Clinical
"We found a missense mutation in the critical pore region in perfect co-segregation with the BFNC phenotype."
Charlier et al. 1998 identifies a KCNQ3 pore-region missense variant co-segregating with BFNC.
ORPHA:1949 SUPPORT Other
"KCNQ3 | potassium voltage-gated channel subfamily Q member 3 | hgnc:6297 | Disease-causing germline mutation(s) in"
Orphanet identifies KCNQ3 as a disease-causing gene for self-limited neonatal epilepsy.
?

Discussions and Knowledge Gaps

3
Which molecular properties of a KCNQ2 or KCNQ3 variant (mild haploinsufficiency versus dominant-negative strong loss-of-function versus gain-of-function) determine whether it produces self-limiting benign familial neonatal seizures rather than the severe KCNQ2 developmental and epileptic encephalopathy, and can M-current openers be matched to variant class?
CONTROVERSY OPEN gap_bfns_variant_class_severity_determinants
Attached to
pathophysiology#KCNQ2 Pathogenic Variant pathophysiology#KCNQ3 Pathogenic Variant pathophysiology#Kv7.2/Kv7.3 M-Channel Dysfunction
The same gene produces strikingly different severity. Recent cohorts associate single-allele truncating/NMD and nontransmembrane variants with SeL(F)NE, and transmembrane or pore-region missense variants with DEE, but the evidence is retrospective and not deterministic for an individual variant. Functional mechanism, allelic context, and KCNQ3-specific evidence remain incomplete. This gap has therapeutic stakes because M-current openers and sodium-channel blockers may behave differently across loss-of-function, dominant-negative, and gain-of-function variants.
Proposed experiments
KCNQ2/KCNQ3 variant-class functional and pharmacology panel
heterologous channel electrophysiology and pharmacology experiment Relation: this experiment is of type this experiment type This experiment is of type heterologous channel electrophysiology and pharmacology experiment.
exp_bfns_variant_class_functional_panel
Express matched benign-familial-neonatal-seizure and developmental and epileptic encephalopathy variants of KCNQ2 and KCNQ3 in a shared heterologous background, with and without co-expressed wild-type subunit, and measure M-current density, activation and deactivation kinetics, dominant-negative suppression, and pharmacological rescue by retigabine.
Perturbations
KCNQ2/KCNQ3 variant expression
pathophysiology#Kv7.2/Kv7.3 M-Channel Dysfunction
Introduce individual benign and encephalopathy-associated variants, alone and co-expressed with wild-type subunit, to quantify variant-class effects on channel function.
KCNQ2 hgnc:6296 HUGO Gene Nomenclature Committee (hgnc) Relation: this perturbation targets this gene This perturbation targets KCNQ2 (hgnc:6296). hgnc:6296 is a gene from the HUGO Gene Nomenclature Committee. KCNQ3 hgnc:6297 HUGO Gene Nomenclature Committee (hgnc) Relation: this perturbation targets this gene This perturbation targets KCNQ3 (hgnc:6297). hgnc:6297 is a gene from the HUGO Gene Nomenclature Committee.
Readouts
M-current density and pharmacological rescue
pathophysiology#Loss of M-Current Control of Neuronal Excitability
membrane repolarization GO:0086009 Gene Ontology (GO) Relation: this readout reports on this biological process This readout reports on decreased membrane repolarization (GO:0086009). GO:0086009 is a biological process from the Gene Ontology. ↓ DECREASED
patch-clamp electrophysiology assay Relation: this readout is measured by this assay This readout is measured by patch-clamp electrophysiology assay.
Direction: POSITIVE
Controls
Wild-type channel
Wild-type KCNQ2/KCNQ3 heteromeric channels.
Benign versus encephalopathy variant comparison
Matched benign and encephalopathy variants assayed in the same background.
Decision criterion
A variant-class-to-severity model is supported if encephalopathy variants reproducibly cause stronger M-current suppression or dominant-negative behaviour than benign variants, and if retigabine rescue differs predictably by class.
Would support
pathophysiology#KCNQ2 Pathogenic Variant pathophysiology#KCNQ3 Pathogenic Variant pathophysiology#Kv7.2/Kv7.3 M-Channel Dysfunction pathophysiology#Loss of M-Current Control of Neuronal Excitability
Show evidence (2 references)
PMID:22275249 SUPPORT Human Clinical
"A few reports on patients with a KCNQ2 mutation with a more severe outcome exist, but a definite relationship has not been established."
Weckhuysen et al. show that severe KCNQ2 outcomes were recognized before a definite genotype-severity relationship was established, framing the open question of what distinguishes benign from encephalopathic variants.
PMID:41988220 SUPPORT Human Clinical
"Clear topology-phenotype patterns emerged: transmembrane missense variants-especially S5-pore-S6-were enriched in DEE, whereas C-terminal/nontransmembrane variants were associated with SeL(F)NE and benign outcomes."
This 30-patient cohort strengthens a topology-severity association but remains too small and observational to close the variant-level prediction question.
What developmental changes drive the spontaneous remission of benign familial neonatal seizures within the first months of life, given that the mutant KCNQ2/KCNQ3 channel continues to be expressed throughout adulthood?
KNOWLEDGE GAP OPEN gap_bfns_self_limiting_developmental_basis
Attached to
pathophysiology#Neonatal Neuronal Hyperexcitability
Seizures remit despite lifelong expression of the causal variant, so remission cannot be explained by loss of the mutant channel. A 2026 paired mouse-model study found timely excitability recovery and activation of neurodevelopmental signaling in the SeLNE model, whereas recovery was delayed in the DEE model. The responsible cell programs and their fidelity to human remission remain unresolved, as do the possible contributions of compensatory potassium conductances, chloride homeostasis, and inhibitory circuit maturation.
Proposed experiments
Developmental time-course of excitability and chloride homeostasis
developmental time-course electrophysiology experiment Relation: this experiment is of type this experiment type This experiment is of type developmental time-course electrophysiology experiment.
exp_bfns_developmental_timecourse
In patient-derived iPSC cortical neurons and in Kcnq2/Kcnq3 knock-in mice, map M-current density, KCC2 expression, GABA reversal potential, and network excitability across the equivalent postnatal maturation window to identify which change coincides with seizure remission.
Readouts
Maturation of excitability and inhibition
pathophysiology#Neonatal Neuronal Hyperexcitability
membrane repolarization GO:0086009 Gene Ontology (GO) Relation: this readout reports on this biological process This readout reports on decreased membrane repolarization (GO:0086009). GO:0086009 is a biological process from the Gene Ontology. ↓ DECREASED trans-synaptic signaling GO:0099537 Gene Ontology (GO) Relation: this readout reports on this biological process This readout reports on dysregulated trans-synaptic signaling (GO:0099537). GO:0099537 is a biological process from the Gene Ontology. ↕ DYSREGULATED
patch-clamp electrophysiology assay Relation: this readout is measured by this assay This readout is measured by patch-clamp electrophysiology assay. multielectrode array recording Relation: this readout is measured by this assay This readout is measured by multielectrode array recording.
Direction: POSITIVE
Controls
Isogenic corrected neurons
Neurons in which the KCNQ2/KCNQ3 variant is corrected.
Wild-type littermate mice
Age-matched wild-type mice for the developmental time-course.
Decision criterion
A developmental driver of remission is supported if a specific maturational change (compensatory K+ conductance, KCC2/chloride switch, or inhibitory maturation) reproducibly coincides with the normalization of network excitability despite continued mutant-channel expression.
Would support
pathophysiology#Neonatal Neuronal Hyperexcitability
Show evidence (3 references)
PMID:18483067 SUPPORT Model Organism
"exhibits the remarkable feature of clinical remission within a few weeks of onset and a favourable prognosis, sparing cognitive abilities despite persistent expression of the mutant KCNQ2 or KCNQ3 potassium channels throughout adulthood."
Singh et al. frame the paradox directly: remission occurs despite persistent expression of the mutant channel, motivating a developmental rather than channel-loss explanation.
PMID:36939707 SUPPORT Other
"Seizures tend to remit during infancy or early childhood and are therefore called "self-limited"."
The ILAE review documents the self-limited course whose developmental basis this gap seeks to explain.
PMID:41051877 SUPPORT Model Organism
"Conversely, SeLNE mice exhibited pronounced activation of neurodevelopmental signaling pathways."
The paired mouse study supplies a specific developmental signal but does not identify which program is necessary for human remission.
Why do earlier homozygous Kcnq2/Kcnq3 knock-in models show seizures persisting into adulthood while a newer Kcnq2-SeLNE model shows timely excitability recovery, and which allele, dosage, and developmental context best models the self-limited human course?
HUMAN MODEL MISMATCH OPEN gap_bfns_mouse_model_self_limiting_fidelity
Attached to
pathophysiology#Kv7.2/Kv7.3 M-Channel Dysfunction pathophysiology#Loss of M-Current Control of Neuronal Excitability pathophysiology#Neonatal Neuronal Hyperexcitability
Earlier knock-in mice carrying human BFNC variants reproduce reduced M-current and lower seizure thresholds, but homozygous animals have recurrent seizures into adulthood. A newer phenotypic Kcnq2-SeLNE model instead shows timely recovery of neuronal excitability. This discrepancy may reflect allele, zygosity, background, brain region, or outcome definition and prevents treating either mouse time course as a direct surrogate for human remission.
Proposed experiments
Human iPSC cortical-organoid remission-window experiment
isogenic cortical organoid network-maturation experiment Relation: this experiment is of type this experiment type This experiment is of type isogenic cortical organoid network-maturation experiment.
exp_bfns_human_ipsc_remission_readout
Generate patient-derived and isogenic-corrected human cortical organoids carrying benign-familial-neonatal-seizure KCNQ2/KCNQ3 variants and track M-current, network excitability, and its maturational normalization over extended culture, comparing the trajectory against the persistent-seizure mouse phenotype.
Model systems
BFNS human iPSC-derived cortical organoid
Human cortical organoid carrying benign-familial-neonatal-seizure KCNQ2/KCNQ3 variants, used for M-current and network-maturation readouts.
ORGANOID namo:Organoid link
human NCBITaxon:9606 NCBI Taxonomy (NCBITaxon) Relation: this experimental model is built in this organism This experimental model is built in human, annotated with Homo sapiens (NCBITaxon:9606). NCBITaxon:9606 is an organism from the NCBI Taxonomy.
cerebral cortex UBERON:0000956 Uberon multi-species anatomy ontology (UBERON) Relation: this experimental model uses this anatomical location This experimental model uses cerebral cortex (UBERON:0000956). UBERON:0000956 is an anatomical location from the Uberon multi-species anatomy ontology.
cortical neuron CL:0000540 Cell Ontology (CL) Relation: this experimental model uses this cell type This experimental model uses cortical neuron, annotated with neuron (CL:0000540). CL:0000540 is a cell type from the Cell Ontology. neural progenitor cell CL:0011020 Cell Ontology (CL) Relation: this experimental model uses this cell type This experimental model uses neural progenitor cell (CL:0011020). CL:0011020 is a cell type from the Cell Ontology.
Perturbations
KCNQ2/KCNQ3 variant correction or knock-in
pathophysiology#Kv7.2/Kv7.3 M-Channel Dysfunction
Correct or introduce benign-familial-neonatal-seizure variants in an isogenic human iPSC background to compare M-current and network maturation.
KCNQ2 hgnc:6296 HUGO Gene Nomenclature Committee (hgnc) Relation: this perturbation targets this gene This perturbation targets KCNQ2 (hgnc:6296). hgnc:6296 is a gene from the HUGO Gene Nomenclature Committee. KCNQ3 hgnc:6297 HUGO Gene Nomenclature Committee (hgnc) Relation: this perturbation targets this gene This perturbation targets KCNQ3 (hgnc:6297). hgnc:6297 is a gene from the HUGO Gene Nomenclature Committee.
Readouts
M-current and network-maturation trajectory
pathophysiology#Neonatal Neuronal Hyperexcitability
membrane repolarization GO:0086009 Gene Ontology (GO) Relation: this readout reports on this biological process This readout reports on decreased membrane repolarization (GO:0086009). GO:0086009 is a biological process from the Gene Ontology. ↓ DECREASED
patch-clamp electrophysiology assay Relation: this readout is measured by this assay This readout is measured by patch-clamp electrophysiology assay. multielectrode array recording Relation: this readout is measured by this assay This readout is measured by multielectrode array recording.
Direction: POSITIVE
Controls
Isogenic corrected organoids
Matched organoids in which the variant is corrected.
Persistent-seizure mouse comparison
Kcnq2/Kcnq3 knock-in mouse phenotype as the divergent model reference.
Decision criterion
Human fidelity of the self-limiting course is supported if human organoid network hyperexcitability normalizes over maturation despite persistent mutant-channel expression, diverging from the persistent-seizure mouse trajectory.
Would support
pathophysiology#Kv7.2/Kv7.3 M-Channel Dysfunction pathophysiology#Loss of M-Current Control of Neuronal Excitability pathophysiology#Neonatal Neuronal Hyperexcitability
Show evidence (2 references)
PMID:18483067 SUPPORT Model Organism
"Both Kcnq2(A306T/A306T) and Kcnq3(G311V/G311V) homozygous mutant mice exhibited early onset spontaneous generalized tonic-clonic seizures concurrent with a significant reduction in amplitude and increased deactivation kinetics of the neuronal M-current."
The mouse model recapitulates the M-current defect and produces seizures, but with a course that diverges from the human self-limiting phenotype, defining the model-mismatch question.
PMID:41051877 SUPPORT Model Organism
"Notably, whereas SeLNE mice showed timely recovery of excitability, DEE mice displayed delayed restoration of abnormal excitability in CA1 excitatory neurons."
The newer paired model reproduces an age-limited recovery trajectory, creating a direct contrast with the persistent-seizure homozygous models.
⚙

Pathophysiology

6
KCNQ2 Pathogenic Variant
A heterozygous pathogenic KCNQ2 variant is the more common initiating lesion in self-limited familial neonatal epilepsy. Mild loss-of-function or haploinsufficiency is typical of the self-limited end of the spectrum, although variant class alone does not determine clinical severity.
KCNQ2 hgnc:6296 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves KCNQ2 (hgnc:6296). hgnc:6296 is a gene from the HUGO Gene Nomenclature Committee.
Downstream
Kv7.2/Kv7.3 M-Channel Dysfunction Pathogenic KCNQ2 variants impair Kv7.2-containing neuronal M channels.
Show evidence (1 reference)
PMID:9425895 SUPPORT Human Clinical
"Five other BFNC probands were shown to have KCNQ2 mutations, including two transmembrane missense mutations, two frameshifts and one splice-site mutation."
The original discovery series identifies heterozygous KCNQ2 variants as initiating lesions in BFNC.
KCNQ3 Pathogenic Variant
A heterozygous pathogenic KCNQ3 variant is a less common alternative initiating lesion in self-limited familial neonatal epilepsy. The original BFNC family carried a pore-region missense variant that co-segregated with the phenotype.
KCNQ3 hgnc:6297 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves KCNQ3 (hgnc:6297). hgnc:6297 is a gene from the HUGO Gene Nomenclature Committee.
Downstream
Kv7.2/Kv7.3 M-Channel Dysfunction Pathogenic KCNQ3 variants impair Kv7.3-containing neuronal M channels.
Show evidence (1 reference)
PMID:9425900 SUPPORT Human Clinical
"We found a missense mutation in the critical pore region in perfect co-segregation with the BFNC phenotype."
The original family establishes a heterozygous KCNQ3 pore variant as an alternative BFNC lesion.
Kv7.2/Kv7.3 M-Channel Dysfunction
KCNQ2 (Kv7.2) and KCNQ3 (Kv7.3) subunits co-assemble in the neuronal M channel. Pathogenic variants compromise this voltage-gated potassium channel complex and reduce or alter its current. This node captures the channel defect separately from its effect on neuronal excitability.
neuron CL:0000540 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves neuron (CL:0000540). CL:0000540 is a cell type from the Cell Ontology.
KCNQ2 hgnc:6296 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves KCNQ2 (hgnc:6296). hgnc:6296 is a gene from the HUGO Gene Nomenclature Committee. KCNQ3 hgnc:6297 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves KCNQ3 (hgnc:6297). hgnc:6297 is a gene from the HUGO Gene Nomenclature Committee.
voltage-gated potassium channel activity GO:0005249 Gene Ontology (GO) Relation: this pathophysiological event involves this molecular function This pathophysiological event involves decreased voltage-gated potassium channel activity (GO:0005249). GO:0005249 is a molecular function from the Gene Ontology. ↓ DECREASED
cerebral cortex UBERON:0000956 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in cerebral cortex (UBERON:0000956). UBERON:0000956 is an anatomical location from the Uberon multi-species anatomy ontology.
Experimental models
Heterologous KCNQ2/KCNQ3 M-channel expression assay OTHER Assays the biophysical and pharmacologic properties of Kv7.2/Kv7.3 channels that constitute neuronal M-current.
Downstream
Loss of M-Current Control of Neuronal Excitability Dysfunction of Kv7.2/Kv7.3 channels attenuates neuronal M-current.
Show evidence (2 references)
PMID:9836639 SUPPORT In Vitro
"It is concluded that both these subunits contribute to the native M-current."
Wang et al. 1998 directly demonstrates that KCNQ2 and KCNQ3 subunits constitute the M-channel.
PMID:18483067 SUPPORT Model Organism
"Both Kcnq2(A306T/A306T) and Kcnq3(G311V/G311V) homozygous mutant mice exhibited early onset spontaneous generalized tonic-clonic seizures concurrent with a significant reduction in amplitude and increased deactivation kinetics of the neuronal M-current."
Knock-in models of both human BFNC alleles directly demonstrate reduced and kinetically altered M-current.
Loss of M-Current Control of Neuronal Excitability
The slowly activating, non-inactivating M-current operates in the subthreshold voltage range and restrains repetitive neuronal firing. Reduced M-current removes this stabilizing control of membrane potential.
neuron CL:0000540 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves neuron (CL:0000540). CL:0000540 is a cell type from the Cell Ontology.
regulation of membrane potential GO:0042391 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves dysregulated regulation of membrane potential (GO:0042391). GO:0042391 is a biological process from the Gene Ontology. ↕ DYSREGULATED
Downstream
Neonatal Neuronal Hyperexcitability Loss of the M-current brake permits excessive repetitive neuronal firing.
Show evidence (1 reference)
PMID:9836639 SUPPORT In Vitro
"The M-current regulates the subthreshold electrical excitability of many neurons, determining their firing properties and responsiveness to synaptic input."
The functional study establishes M-current as a regulator of subthreshold neuronal excitability.
Neonatal Neuronal Hyperexcitability
Reduced M-current produces excessive firing and hypersynchronous activity in neonatal neuronal networks. The human mechanism of remission is not established. A 2026 Kcnq2 model study found timely recovery of excitability in a SeLNE model but delayed recovery in a DEE model, making age-limited recovery a supported animal-model result rather than a settled human mechanism.
neuron CL:0000540 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves neuron (CL:0000540). CL:0000540 is a cell type from the Cell Ontology. pyramidal neuron CL:0000598 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves pyramidal neuron (CL:0000598). CL:0000598 is a cell type from the Cell Ontology.
neuronal action potential GO:0019228 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased neuronal action potential (GO:0019228). GO:0019228 is a biological process from the Gene Ontology. ↑ INCREASED
cerebral cortex UBERON:0000956 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in cerebral cortex (UBERON:0000956). UBERON:0000956 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Neonatal Focal Seizure Generation Developmentally restricted neuronal hyperexcitability generates focal neonatal seizures.
Show evidence (2 references)
PMID:36939707 SUPPORT Other
"Seizures tend to remit during infancy or early childhood and are therefore called "self-limited"."
The ILAE review confirms the transient, age-limited nature of the seizure phenotype.
PMID:41051877 SUPPORT Model Organism
"Notably, whereas SeLNE mice showed timely recovery of excitability, DEE mice displayed delayed restoration of abnormal excitability in CA1 excitatory neurons."
The paired mouse models support developmentally timed excitability recovery as a candidate explanation for phenotypic divergence.
Neonatal Focal Seizure Generation
Hyperexcitable neonatal networks generate recurrent focal seizures with tonic, clonic, and autonomic manifestations. This node separates seizure generation from the individual clinical semiologies and from the EEG pattern that reports the ictal activity.
neuron CL:0000540 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves neuron (CL:0000540). CL:0000540 is a cell type from the Cell Ontology.
cerebral cortex UBERON:0000956 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in cerebral cortex (UBERON:0000956). UBERON:0000956 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Neonatal Seizure The hyperexcitable neonatal network state manifests as neonatal seizures.
Focal-onset Seizure Network-level hyperexcitability manifests as focal neonatal seizures.
Focal Tonic Seizure Neonatal network hyperexcitability can present with focal tonic semiology.
Focal Clonic Seizure Neonatal network hyperexcitability can present with focal clonic motor semiology.
Generalized Tonic Seizure Focal neonatal seizures can secondarily generalize into tonic seizures.
Focal Autonomic Seizure Focal neonatal seizures can include autonomic features.
Apnea Ictal autonomic involvement can produce apnea during neonatal seizures.
Circumoral Cyanosis Apneic ictal events can produce circumoral cyanosis.
Clonus Hyperexcitable neonatal motor networks produce clonic movements.
Limb Myoclonus Hyperexcitable neonatal motor networks can produce limb myoclonic jerks.
Show evidence (1 reference)
PMID:20437616 SUPPORT Other
"video EEG identifies seizures as focal onset with tonic stiffening of limb(s) and some migration during each seizure's evolution."
GeneReviews documents the focal neonatal seizure pattern and its tonic, migrating semiology.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Benign Neonatal Seizures Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

11
Nervous System 1
Focal-onset Seizure VERY_FREQUENT HP:0007359 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Focal-onset seizure (HP:0007359). HP:0007359 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
ORPHA:1949 SUPPORT Other
"HP:0007359 | Focal-onset seizure | Very frequent (99-80%)"
Orphanet's curated HPO table classifies focal-onset seizures as very frequent.
Respiratory 1
Apnea FREQUENT HP:0002104 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Apnea (HP:0002104). HP:0002104 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
ORPHA:1949 SUPPORT Other
"HP:0002104 | Apnea | Frequent (79-30%)"
Orphanet's curated HPO table classifies apnea as frequent.
PMID:28926830 SUPPORT Human Clinical
"Refractory seizures occurred in the early neonatal period with similar seizure type, including tonic features, apnea, and desaturation."
KCNQ2 case series documents ictal apnea as a recurrent feature.
Other 9
Neonatal Seizure VERY_FREQUENT HP:0032807 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Neonatal seizure (HP:0032807). HP:0032807 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
ORPHA:1949 SUPPORT Other
"HP:0032807 | Neonatal seizure | Very frequent (99-80%)"
Orphanet's curated HPO table classifies neonatal seizures as very frequent.
PMID:36939707 SUPPORT Other
"autosomal dominant disorders characterized by neonatal- or infantile-onset focal motor seizures and the absence of neurodevelopmental complications."
ILAE review supports neonatal-onset focal motor seizures as the defining feature.
Focal Tonic Seizure VERY_FREQUENT HP:0011167 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Focal tonic seizure (HP:0011167). HP:0011167 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
ORPHA:1949 SUPPORT Other
"HP:0011167 | Focal tonic seizure | Very frequent (99-80%)"
Orphanet's curated HPO table classifies focal tonic seizures as very frequent.
PMID:28926830 SUPPORT Human Clinical
"Refractory seizures occurred in the early neonatal period with similar seizure type, including tonic features, apnea, and desaturation."
KCNQ2 case series describes characteristic tonic seizures with apnea/desaturation.
Focal Clonic Seizure VERY_FREQUENT HP:0002266 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Focal clonic seizure (HP:0002266). HP:0002266 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
ORPHA:1949 SUPPORT Other
"HP:0002266 | Focal clonic seizure | Very frequent (99-80%)"
Orphanet's curated HPO table classifies focal clonic seizures as very frequent.
Clonus FREQUENT HP:0002169 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Clonus (HP:0002169). HP:0002169 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
ORPHA:1949 SUPPORT Other
"HP:0002169 | Clonus | Frequent (79-30%)"
Orphanet's curated HPO table classifies clonus as frequent.
Generalized Tonic Seizure FREQUENT HP:0010818 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Generalized tonic seizure (HP:0010818). HP:0010818 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
ORPHA:1949 SUPPORT Other
"HP:0010818 | Generalized tonic seizure | Frequent (79-30%)"
Orphanet's curated HPO table classifies generalized tonic seizures as frequent.
Focal Autonomic Seizure FREQUENT HP:0011154 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Focal autonomic seizure (HP:0011154). HP:0011154 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
ORPHA:1949 SUPPORT Other
"HP:0011154 | Focal autonomic seizure | Frequent (79-30%)"
Orphanet's curated HPO table classifies focal autonomic seizures as frequent.
Circumoral Cyanosis FREQUENT HP:0032556 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Circumoral cyanosis (HP:0032556). HP:0032556 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
ORPHA:1949 SUPPORT Other
"HP:0032556 | Circumoral cyanosis | Frequent (79-30%)"
Orphanet's curated HPO table classifies circumoral cyanosis as frequent.
Limb Myoclonus FREQUENT HP:0045084 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Limb myoclonus (HP:0045084). HP:0045084 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
ORPHA:1949 SUPPORT Other
"HP:0045084 | Limb myoclonus | Frequent (79-30%)"
Orphanet's curated HPO table classifies limb myoclonus as frequent.
Focal EEG Discharges with Secondary Generalization VERY_FREQUENT HP:0011188 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Focal EEG discharges with secondary generalization (HP:0011188). HP:0011188 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
ORPHA:1949 SUPPORT Other
"HP:0011188 | Focal EEG discharges with secondary generalization | Very frequent (99-80%)"
Orphanet's curated HPO table classifies this EEG pattern as very frequent.
🧬

Genetic Associations

2
KCNQ2 (Causal heterozygous pathogenic variant)
Gene: KCNQ2 hgnc:6296 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is KCNQ2 (hgnc:6296). hgnc:6296 is a gene from the HUGO Gene Nomenclature Committee.
Autosomal dominant with incomplete penetrance
Show evidence (4 references)
PMID:9425895 SUPPORT Human Clinical
"Five other BFNC probands were shown to have KCNQ2 mutations, including two transmembrane missense mutations, two frameshifts and one splice-site mutation."
Singh et al. 1998 established KCNQ2 as the major causal gene for benign familial neonatal convulsions.
ORPHA:1949 SUPPORT Other
"KCNQ2 | potassium voltage-gated channel subfamily Q member 2 | hgnc:6296 | Disease-causing germline mutation(s) in"
Orphanet gene table confirms KCNQ2 as a disease-causing gene.
PMID:41988220 SUPPORT Human Clinical
"Clear topology-phenotype patterns emerged: transmembrane missense variants-especially S5-pore-S6-were enriched in DEE, whereas C-terminal/nontransmembrane variants were associated with SeL(F)NE and benign outcomes."
The cohort supports a topology-associated severity gradient while not making the association deterministic for an individual variant.
+ 1 more reference
KCNQ3 (Causal heterozygous pathogenic variant)
Gene: KCNQ3 hgnc:6297 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is KCNQ3 (hgnc:6297). hgnc:6297 is a gene from the HUGO Gene Nomenclature Committee.
Autosomal dominant with incomplete penetrance
Show evidence (2 references)
PMID:9425900 SUPPORT Human Clinical
"We screened KCNQ3 for mutations in the large BFNC family previously linked to chromosome 8q24 in the same marker interval. We found a missense mutation in the critical pore region in perfect co-segregation with the BFNC phenotype."
Charlier et al. 1998 established KCNQ3 as a causal BFNC gene.
ORPHA:1949 SUPPORT Other
"KCNQ3 | potassium voltage-gated channel subfamily Q member 3 | hgnc:6297 | Disease-causing germline mutation(s) in"
Orphanet gene table confirms KCNQ3 as a disease-causing gene.
🗃️

External Assertions

1
Orphanet self-limited neonatal epilepsy record
Orphanet structured disease record ORPHA:1949
Orphanet identifies self-limited (familial) neonatal epilepsy (a synonym of benign familial neonatal seizures) as ORPHA:1949 and provides an exact cross-reference to MONDO:0016027.
Show evidence (2 references)
ORPHA:1949 SUPPORT Other
"MONDO:0016027 | Exact"
Orphanet's cross-reference table maps ORPHA:1949 exactly to MONDO:0016027.
ORPHA:1949 SUPPORT Other
"OMIM:121200 | Exact"
Orphanet also provides an exact OMIM cross-reference for benign familial neonatal seizures.
💊

Medical Actions

2
Carbamazepine
Action: anticonvulsant agent therapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is anticonvulsant agent therapy, annotated with Anticonvulsant Therapy (NCIT:C64172). NCIT:C64172 is a clinical intervention from the NCI Thesaurus. Ontology label: Anticonvulsant Therapy NCIT:C64172
Agent: carbamazepine CHEBI:3387 Chemical Entities of Biological Interest (CHEBI) Relation: this treatment uses this therapeutic agent This treatment uses carbamazepine (CHEBI:3387). CHEBI:3387 is a therapeutic agent from Chemical Entities of Biological Interest.
Carbamazepine, a sodium-channel-blocking antiseizure medication, is frequently reported to control KCNQ2/KCNQ3-related neonatal seizures. Support comes from small retrospective case series and a systematic review whose 29 included studies were all retrospective; it does not establish a randomized first-line superiority claim. Some infants with the self-limited phenotype also become seizure-free without treatment.
Target Phenotypes: Neonatal seizure HP:0032807 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Neonatal seizure (HP:0032807). HP:0032807 is a phenotype from the Human Phenotype Ontology. Focal-onset seizure HP:0007359 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Focal-onset seizure (HP:0007359). HP:0007359 is a phenotype from the Human Phenotype Ontology.
Show evidence (4 references)
PMID:37827512 SUPPORT Human Clinical
"prompted the use of CBZ that was effective in all."
Carbamazepine was effective in all four neonates given the targeted therapy in this case series.
PMID:28926830 SUPPORT Human Clinical
"Prompt recognition of this pattern led to early treatment with carbamazepine in the 2 most recent cases."
Earlier KCNQ2 case series also supports carbamazepine as targeted therapy.
PMID:36948217 SUPPORT Other
"CONCLUSION: Phenobarbital or carbamazepine appears to be the most effective antiseizure medication for children with a "benign" variant."
The systematic review supports carbamazepine as a commonly effective option while its retrospective evidence base limits causal ranking.
+ 1 more reference
Sodium-channel-blocking Antiseizure Medication Therapy
Action: anticonvulsant agent therapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is anticonvulsant agent therapy, annotated with Anticonvulsant Therapy (NCIT:C64172). NCIT:C64172 is a clinical intervention from the NCI Thesaurus. Ontology label: Anticonvulsant Therapy NCIT:C64172
Agent: carbamazepine CHEBI:3387 Chemical Entities of Biological Interest (CHEBI) Relation: this treatment uses this therapeutic agent This treatment uses carbamazepine (CHEBI:3387). CHEBI:3387 is a therapeutic agent from Chemical Entities of Biological Interest. oxcarbazepine CHEBI:7824 Chemical Entities of Biological Interest (CHEBI) Relation: this treatment uses this therapeutic agent This treatment uses oxcarbazepine (CHEBI:7824). CHEBI:7824 is a therapeutic agent from Chemical Entities of Biological Interest.
Sodium-channel blockers as a class, including carbamazepine and oxcarbazepine in the cited cohorts, are often used as targeted therapy for KCNQ2/KCNQ3-related neonatal seizures. Recent cohorts associate early use or oxcarbazepine exposure with seizure control, but treatment selection was not randomized, the cohorts span both self-limited and DEE phenotypes, and developmental benefit has not been established.
Target Phenotypes: Neonatal seizure HP:0032807 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Neonatal seizure (HP:0032807). HP:0032807 is a phenotype from the Human Phenotype Ontology.
Show evidence (4 references)
PMID:28926830 SUPPORT Human Clinical
"Early recognition of the electroclinical phenotype by using aEEG may direct genetic testing and a precision medicine approach with sodium channel blockers in neonates with KCNQ2 mutations."
The case series explicitly recommends sodium-channel blockers as targeted precision therapy in KCNQ2 neonatal epilepsy.
PMID:40236662 SUPPORT Human Clinical
"Among the 12 patients who failed to respond to the first monotherapy, 9 patients achieved a seizure free status with oxcarbazepine, which was used as the second-line monotherapy or as add-on therapy."
A broader neonatal/infantile self-limited focal-epilepsy cohort reports oxcarbazepine-associated seizure freedom after initial monotherapy failure.
PMID:41988220 SUPPORT Human Clinical
"Oxcarbazepine was often associated with seizure control after phenobarbital nonresponse, but this observational signal should not be interpreted as causal."
The KCNQ2 cohort reports the association and explicitly limits causal interpretation.
+ 1 more reference
🔬

Diagnosis

3
KCNQ2/KCNQ3 molecular genetic testing
Targeted KCNQ2/KCNQ3 sequencing or epilepsy gene-panel/whole-exome sequencing identifies pathogenic variants. Molecular results must be interpreted with the neonatal phenotype and EEG because KCNQ2 variants span self-limited epilepsy and KCNQ2-DEE.
molecular genetic testing NCIT:C19770 NCI Thesaurus (NCIT)
Results: Heterozygous pathogenic or likely pathogenic variants in KCNQ2 or KCNQ3 support the diagnosis.
Show evidence (2 references)
PMID:20437616 SUPPORT Other
"The diagnosis of a KCNQ2-related disorder is established in a proband with suggestive findings and a heterozygous pathogenic variant in KCNQ2 identified by molecular genetic testing."
GeneReviews requires both compatible findings and a heterozygous pathogenic KCNQ2 variant.
PMID:36939707 SUPPORT Other
"we describe important clues in recognition of these syndromes, diagnostic steps including genetic testing, management, and genetic counseling."
ILAE Genetics Commission supports genetic testing as part of the diagnostic workup.
Amplitude-integrated EEG (aEEG)
Amplitude-integrated EEG can capture a distinctive ictal pattern in some neonates with KCNQ2/3 variants, allowing early electroclinical recognition while molecular results are pending. The published evidence is from small retrospective case series across the KCNQ2/3 neonatal epilepsy spectrum, not a validated test specific to SeL(F)NE.
electroencephalography NCIT:C38054 NCI Thesaurus (NCIT)
Results: A sudden rise in both aEEG margins followed by marked amplitude depression is a reported ictal pattern that may prompt KCNQ2/KCNQ3 testing and treatment consideration.
Show evidence (2 references)
PMID:28926830 SUPPORT Human Clinical
"A distinct aEEG seizure pattern, consisting of a sudden rise of the lower and upper margin of the aEEG, followed by a marked depression of the aEEG amplitude, was found in 8 of the 9 patients."
Multicenter case series defines a distinctive aEEG pattern in KCNQ2-related neonatal epilepsy.
PMID:37827512 SUPPORT Human Clinical
"Recognition of the distinctive ictal aEEG pattern in the NICU allowed early and effective targeted therapy with CBZ in four neonates, well before genetic results became available."
A subsequent case series confirms aEEG pattern recognition enables early targeted therapy.
Neonatal EEG background and neurologic examination
Conventional EEG background and neonatal neurologic examination help distinguish a likely self-limited course from KCNQ2-DEE. Burst suppression, profound discontinuity, markedly abnormal background, or abnormal tone are red flags for adverse developmental outcome rather than defining features of SeL(F)NE.
electroencephalography NCIT:C38054 NCI Thesaurus (NCIT)
Results: A relatively preserved background and normal examination support the self-limited end; marked abnormalities require longitudinal developmental surveillance and reassessment for KCNQ2-DEE.
Show evidence (2 references)
PMID:41988220 SUPPORT Human Clinical
"burst-suppression/profound discontinuity consistently signaled adverse neurodevelopment."
The 30-patient cohort links severely abnormal EEG background to adverse outcome.
PMID:42081271 SUPPORT Human Clinical
"Factors in the neonatal period associated with abnormal developmental outcome included neurological abnormalities (e.g., abnormal tone) and markedly abnormal neonatal EEG background"
The multicenter cohort independently identifies examination and EEG-background red flags.
📈

Progression

3
Neonatal seizure onset
Age: First week of life
Seizures characteristically begin in the first days to first week of life in an otherwise well-appearing term infant.
Show evidence (2 references)
ORPHA:1949 SUPPORT Other
"Age of onset: Neonatal"
Orphanet's natural-history section classifies onset as neonatal.
PMID:36939707 SUPPORT Other
"autosomal dominant disorders characterized by neonatal- or infantile-onset focal motor seizures and the absence of neurodevelopmental complications."
The ILAE Genetics Commission review summarizes neonatal/infantile onset of focal motor seizures.
Spontaneous remission
Age: Within first year of life
Seizures characteristically remit during infancy or early childhood, hence the "self-limited" designation; long-term neurodevelopment is generally normal.
Show evidence (2 references)
ORPHA:1949 SUPPORT Other
"seizures onset typically in the first week of life, in otherwise healthy newborns, and usually resolving within the first year of life."
Orphanet definition supports first-week onset and resolution within the first year.
PMID:36939707 SUPPORT Other
"Seizures tend to remit during infancy or early childhood and are therefore called "self-limited"."
ILAE literacy review supports spontaneous remission in infancy/early childhood.
Later seizure susceptibility
Age: Later childhood through adulthood
The neonatal epilepsy is self-limited, but later seizures can occur. GeneReviews estimates that about 30% of individuals with KCNQ2-related self-limited familial neonatal epilepsy develop epileptic seizures later in life; this estimate should not be generalized automatically to KCNQ3.
Show evidence (1 reference)
PMID:20437616 SUPPORT Other
"About 30% of individuals with KCNQ2-SLFNE develop epileptic seizures later in life."
GeneReviews directly quantifies later seizure risk in the KCNQ2-related subtype.
🔀

Differential Diagnoses

3

Conditions with similar clinical presentations that must be differentiated from Benign Neonatal Seizures:

KCNQ2 developmental and epileptic encephalopathy MONDO:0013387
Overlapping Features KCNQ2-DEE can begin in the same first postnatal week and share focal tonic seizures, but it represents the severe end of the KCNQ2 spectrum rather than the self-limited syndrome.
Distinguishing Features
  • Multiple daily or drug-resistant neonatal seizures
  • Burst-suppression, profound discontinuity, or multifocal epileptiform EEG background
  • Abnormal neurologic examination and moderate-to-profound developmental impairment
  • Transmembrane or pore-region missense variants are enriched but do not determine outcome alone
Show evidence (2 references)
PMID:20437616 SUPPORT Other
"At onset, EEG shows a burst-suppression pattern or multifocal epileptiform activity; early brain MRI can show basal ganglia hyperdensities and later MRIs may show white matter or general volume loss. Moderate-to-profound developmental impairment is present."
GeneReviews defines EEG, imaging, and developmental features that distinguish KCNQ2-NEO-DEE from KCNQ2-SLFNE.
PMID:41988220 SUPPORT Human Clinical
"Neurodevelopment was normal in 63%; delays occurred only within the DEE cohort."
This cohort supports developmental delay as a boundary with the DEE subgroup.
Benign familial infantile epilepsy MONDO:0017615
Overlapping Features Self-limited familial infantile epilepsy also causes autosomal dominant focal seizures with favorable development but begins in infancy rather than the characteristic neonatal window.
Distinguishing Features
  • Onset after the neonatal period, usually in infancy
Show evidence (1 reference)
PMID:40236662 SUPPORT Human Clinical
"self-limited familial infantile epilepsy (SeLIE, 1 – 24 months)"
The cohort review supplies the infantile age boundary used to distinguish SeLIE.
Acute symptomatic neonatal seizures
Overlapping Features Hypoglycemia, hypocalcemia, intracranial infection, traumatic or structural brain injury, and other acute symptomatic etiologies can present with neonatal seizures and must be excluded before diagnosing a genetic self-limited epilepsy.
Distinguishing Features
  • An identifiable metabolic, infectious, or acquired neurologic trigger
  • Seizure course follows the acute underlying condition rather than a familial self-limited epilepsy pattern
Show evidence (1 reference)
PMID:40236662 SUPPORT Human Clinical
"Children diagnosed with any of the following were excluded from the study: (1) pediatric malignancies, (2) hypoglycaemia, (3) intracranial infections, (4) traumatic brain injuries, (5) hypocalcemia, and (6) symptomatic epilepsy."
The self-limited epilepsy cohort explicitly excluded common acute symptomatic and acquired causes.
📊

Related Datasets

1
KCNQ2 Variants in Neonatal Epilepsy: Clinical Characteristics and Neurodevelopmental Outcomes in 30 Patients. PMID:41988220
Publication-level, two-center cohort integrating whole-exome sequencing, EEG, MRI, treatment, seizure-freedom, and developmental outcome data from 30 neonates with KCNQ2 variants. It compares SeL(F)NE and DEE and therefore must be phenotype-stratified when used for this focal disease.
human WES n=30
Conditions: self-limited familial neonatal epilepsy KCNQ2 developmental and epileptic encephalopathy
PMID:41988220
No dedicated public repository accession was identified in this review; PMID:41988220 identifies the publication-level cohort.
Show evidence (1 reference)
PMID:41988220 SUPPORT Human Clinical
"We conducted a retrospective, two-center study of 30 neonates from 2019 to 2024. All patients underwent whole-exome sequencing with Sanger confirmation"
The methods define the cohort size, ascertainment period, and sequencing basis.
🔬

Clinical Trials

1
NCT05157737 NOT_APPLICABLE UNKNOWN
Observational phenotype and omics study intended to build a KCNQ2-related epilepsy phenotype/sample resource, study genotype-phenotype association, analyze multimodal imaging and EEG brain networks, and seek prognostic biomarkers. It spans the broader KCNQ2 epilepsy spectrum and is not a SeL(F)NE-specific treatment trial.
Show evidence (1 reference)
clinicaltrials:NCT05157737 SUPPORT Human Clinical
"The aims of study on KCNQ2-related epilepsy: (1) establish phenotype database and sample database of KCNQ2-related epilepsy; (2) to establish genotype-phenotype association of KCNQ2-related epilepsy; (3) to study the brain network of KCNQ2-related epilepsy based on multi-modal brain image and..."
The registry summary defines the study as a broad observational phenotype, imaging/EEG, and omics resource.
🧫

Experimental Models

1
Heterologous KCNQ2/KCNQ3 M-channel expression assay OTHER
Heterologous expression of KCNQ2 and KCNQ3 subunits permits electrophysiologic and pharmacologic characterization of homomeric and heteromeric channels and links the two subunits to native neuronal M-current.
KCNQ2 expression KCNQ3 expression KCNQ2/KCNQ3 co-expression
Culture
Heterologous ion-channel expression with voltage-clamp characterization
Publication
PMID:9836639
Pathograph links
Kv7.2/Kv7.3 M-Channel Dysfunction Assays the biophysical and pharmacologic properties of Kv7.2/Kv7.3 channels that constitute neuronal M-current.
Show evidence (1 reference)
PMID:9836639 SUPPORT In Vitro
"It is concluded that both these subunits contribute to the native M-current."
The heterologous channel study directly links KCNQ2 and KCNQ3 subunits to the modeled M-current mechanism.
Show evidence (2 references)
PMID:9836639 SUPPORT In Vitro
"The biophysical properties, sensitivity to pharmacological blockade, and expression pattern of the KCNQ2 and KCNQ3 potassium channels were determined."
The study establishes the heterologous functional characterization used to identify the channel subunits.
PMID:9836639 SUPPORT In Vitro
"It is concluded that both these subunits contribute to the native M-current."
The assay result links KCNQ2/KCNQ3 channel behavior to neuronal M-current.
🐁

Animal Models

2
Kcnq2 A306T and Kcnq3 G311V knock-in lines Mouse (Mus musculus)
Heterozygous knock-in mice carrying human BFNC missense alleles show lower induced-seizure thresholds. Homozygous mice show reduced M-current and spontaneous seizures that persist into adulthood, reproducing channel dysfunction but not the human self-limited time course.
Reduced neuronal M-current amplitude Lower electrically induced seizure threshold Early-onset spontaneous generalized tonic-clonic seizures in homozygous mice Persistent adult seizures without hippocampal neuronal loss
Species
Mouse (Mus musculus)
Genotype
Kcnq2 A306T and Kcnq3 G311V knock-in lines
Genes
KCNQ2 hgnc:6296 HUGO Gene Nomenclature Committee (hgnc) Relation: this experimental model concerns this gene This experimental model concerns KCNQ2 (hgnc:6296). hgnc:6296 is a gene from the HUGO Gene Nomenclature Committee. KCNQ3 hgnc:6297 HUGO Gene Nomenclature Committee (hgnc) Relation: this experimental model concerns this gene This experimental model concerns KCNQ3 (hgnc:6297). hgnc:6297 is a gene from the HUGO Gene Nomenclature Committee.
Show evidence (2 references)
PMID:18483067 SUPPORT Model Organism
"Adult Kcnq2(A306T/+) and Kcnq3(G311V/+) heterozygous knock-in mice exhibited reduced thresholds to electrically induced seizures compared to wild-type littermate mice."
The heterozygous lines reproduce increased seizure susceptibility.
PMID:18483067 SUPPORT Model Organism
"Mice had recurrent seizures into adulthood that triggered molecular plasticity including ectopic neuropeptide Y (NPY) expression in granule cells, but without hippocampal mossy fibre sprouting or neuronal loss."
The persistent adult-seizure course establishes an important mismatch with human remission.
Mouse (Mus musculus)
Paired Kcnq2 models were studied from postnatal day 14 to 28 with brain-slice patch clamp and single-nucleus RNA sequencing. Both models were hyperexcitable, but the SeLNE model recovered excitability on time while the DEE model recovered later and showed different neurodevelopmental transcriptional programs.
High-frequency action-potential firing Timely recovery of excitability in the SeLNE model Delayed excitability recovery in the DEE model
Species
Mouse (Mus musculus)
Genes
KCNQ2 hgnc:6296 HUGO Gene Nomenclature Committee (hgnc) Relation: this experimental model concerns this gene This experimental model concerns KCNQ2 (hgnc:6296). hgnc:6296 is a gene from the HUGO Gene Nomenclature Committee.
Show evidence (2 references)
PMID:41051877 SUPPORT Model Organism
"Using brain slice patch-clamp and single-nucleus RNA sequencing, we revealed developmental dysregulation in two different phenotypic Kcnq2 mice (DEE vs. SeLNE) during postnatal days 14-28 (P14-P28)."
The study defines the paired models, developmental interval, and measurement modalities.
PMID:41051877 SUPPORT Model Organism
"Notably, whereas SeLNE mice showed timely recovery of excitability, DEE mice displayed delayed restoration of abnormal excitability in CA1 excitatory neurons."
The comparative result directly supports the age-limited recovery distinction.
{ }

Source YAML

click to show 
name: Benign Neonatal Seizures
creation_date: "2026-05-13T12:00:00Z"
category: Mendelian
description: >-
  Benign neonatal seizures, now termed self-limited (familial) neonatal
  epilepsy (SeL[F]NE), is an autosomal dominant focal epilepsy syndrome of the
  newborn. Seizures usually begin between two and eight days after term birth
  in an otherwise healthy infant and remit during the first six to 12 months.
  Heterozygous pathogenic variants in KCNQ2 are the most common molecular
  cause, with KCNQ3 variants accounting for a smaller subgroup. Kv7.2 and Kv7.3
  form neuronal M channels; reduced M-current weakens the subthreshold
  potassium conductance that restrains repetitive firing. Development is
  usually normal, but the label "self-limited" does not imply zero later risk:
  some individuals with KCNQ2-related disease have seizures later in life.
  Markedly abnormal neonatal EEG background, abnormal neurologic examination,
  persistent drug-resistant seizures, and developmental impairment instead
  raise concern for KCNQ2-related developmental and epileptic encephalopathy
  (KCNQ2-DEE), the severe end of the KCNQ2 spectrum.
classifications:
  harrisons_chapter:
  - classification_value: NEUROLOGIC
    notes: >-
      Self-limited familial neonatal epilepsy is a focal epilepsy syndrome of
      neonatal onset.
    evidence:
    - reference: PMID:36939707
      reference_title: "ILAE Genetic Literacy Series: Self-limited familial epilepsy syndromes with onset in neonatal age and infancy."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "The self-limited (familial) epilepsies with onset in neonates or infants, formerly called benign familial neonatal and/or infantile epilepsies, are autosomal dominant disorders characterized by neonatal- or infantile-onset focal motor seizures and the absence of neurodevelopmental complications."
      explanation: The ILAE review classifies the condition as a neonatal-onset focal epilepsy syndrome.
disease_term:
  preferred_term: benign neonatal seizures
  term:
    id: MONDO:0016027
    label: benign neonatal seizures
synonyms:
- Benign familial neonatal seizures
- Benign familial neonatal convulsions
- Benign familial neonatal epilepsy
- Self-limited familial neonatal epilepsy
- BFNS
- BFNC
- SeLNE
parents:
- Epilepsy
definitions:
- name: Clinical boundary of self-limited familial neonatal epilepsy
  definition_type: CASE_DEFINITION
  description: >-
    Focal motor seizures begin after a seizure-free interval, typically at age
    two to eight days in an otherwise healthy term infant, and remit by six to
    12 months with generally normal development. Tonic limb stiffening,
    migration during an event, apnea, and cyanosis are characteristic
    semiologies. Acute symptomatic neonatal seizures and KCNQ2-DEE must be
    excluded before assigning the self-limited syndrome.
  scope: >-
    Applies to the neonatal-onset self-limited syndrome, whether familial or de
    novo. Infantile-onset self-limited epilepsy and neonatal-onset
    developmental and epileptic encephalopathy are separate disease
    boundaries.
  evidence:
  - reference: PMID:20437616
    reference_title: "KCNQ2-Related Disorders."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "KCNQ2-SLFNE is characterized by seizures that start in otherwise healthy infants between two and eight days after term birth and spontaneously disappear between the first and the sixth to 12th month of life."
    explanation: GeneReviews supplies the characteristic onset, health status, and remission interval for the KCNQ2-related syndrome.
  - reference: PMID:20437616
    reference_title: "KCNQ2-Related Disorders."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Seizures are characterized by sudden onset with prominent motor involvement, often accompanied by apnea and cyanosis; video EEG identifies seizures as focal onset with tonic stiffening of limb(s) and some migration during each seizure's evolution."
    explanation: GeneReviews defines the characteristic focal motor and autonomic seizure semiology.
- name: Molecular confirmation of KCNQ2-related self-limited familial neonatal epilepsy
  definition_type: DIAGNOSTIC_CRITERIA
  description: >-
    In a proband with the compatible self-limited neonatal phenotype, a
    heterozygous pathogenic KCNQ2 variant establishes a KCNQ2-related
    diagnosis. KCNQ3 is an independently established but less common cause;
    variant interpretation must incorporate phenotype and segregation rather
    than assume that every KCNQ2 or KCNQ3 variant predicts a benign course.
  scope: >-
    The quoted diagnostic statement is specific to KCNQ2-related disease.
    KCNQ3-related cases require the same phenotype-first distinction from other
    neonatal epilepsies.
  evidence:
  - reference: PMID:20437616
    reference_title: "KCNQ2-Related Disorders."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "The diagnosis of a KCNQ2-related disorder is established in a proband with suggestive findings and a heterozygous pathogenic variant in KCNQ2 identified by molecular genetic testing."
    explanation: GeneReviews states the molecular diagnostic requirement for KCNQ2-related disease.
mappings:
  mondo_mappings:
  - term:
      id: MONDO:0016027
      label: benign neonatal seizures
    mapping_predicate: skos:exactMatch
    mapping_source: Orphanet
    mapping_justification: Orphanet ORPHA:1949 (self-limited neonatal epilepsy) lists MONDO:0016027 as an exact cross-reference.
    consistency:
    - reference: ORPHA:1949
      consistent: CONSISTENT
      notes: "ORPHA cross-reference row: MONDO:0016027 | Exact"
external_assertions:
- name: Orphanet self-limited neonatal epilepsy record
  source: Orphanet
  assertion_type: structured_disease_record
  external_id: ORPHA:1949
  url: http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=1949
  description: >-
    Orphanet identifies self-limited (familial) neonatal epilepsy (a synonym of
    benign familial neonatal seizures) as ORPHA:1949 and provides an exact
    cross-reference to MONDO:0016027.
  evidence:
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "MONDO:0016027 | Exact"
    explanation: Orphanet's cross-reference table maps ORPHA:1949 exactly to MONDO:0016027.
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "OMIM:121200 | Exact"
    explanation: Orphanet also provides an exact OMIM cross-reference for benign familial neonatal seizures.
inheritance:
- name: Autosomal dominant
  inheritance_term:
    preferred_term: Autosomal dominant inheritance
    term:
      id: HP:0000006
      label: Autosomal dominant inheritance
  description: >-
    Self-limited familial neonatal epilepsy segregates in an autosomal dominant
    manner in multigenerational families with heterozygous KCNQ2 or KCNQ3
    variants. Most KCNQ2-related self-limited cases inherit the variant from a
    parent; each child of a heterozygous affected individual has a 50% chance
    of inheriting it. Incomplete penetrance and de novo cases occur.
  evidence:
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Autosomal dominant"
    explanation: Orphanet directly lists autosomal dominant inheritance for ORPHA:1949.
  - reference: PMID:9425895
    reference_title: "A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "One type is benign familial neonatal convulsions (BFNC), a dominantly inherited disorder of newborns."
    explanation: The original KCNQ2 discovery paper characterizes BFNC as a dominantly inherited disorder of newborns.
  - reference: PMID:20437616
    reference_title: "KCNQ2-Related Disorders."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Each child of a heterozygous individual with KCNQ2-SLFNE has a 50% chance of inheriting the pathogenic variant."
    explanation: GeneReviews provides the recurrence risk for an affected heterozygous parent.
has_subtypes:
- name: KCNQ2-BFNS
  display_name: KCNQ2-related benign familial neonatal seizures
  description: >-
    The more common molecular subtype, caused by heterozygous loss-of-function
    variants in KCNQ2 on chromosome 20q13.3. Distinct from the more severe
    KCNQ2-related developmental and epileptic encephalopathy (KCNQ2-DEE).
  subtype_term:
    preferred_term: seizures, benign familial neonatal, 1
    term:
      id: MONDO:0007365
      label: seizures, benign familial neonatal, 1
  evidence:
  - reference: PMID:9425895
    reference_title: "A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We have identified a sub-microscopic deletion of chromosome 20q13.3 that co-segregates with seizures in a BFNC family."
    explanation: Singh et al. 1998 maps the KCNQ2-BFNC locus to chromosome 20q13.3.
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "KCNQ2 | potassium voltage-gated channel subfamily Q member 2 | hgnc:6296 | Disease-causing germline mutation(s) in"
    explanation: Orphanet identifies KCNQ2 as a disease-causing gene for self-limited neonatal epilepsy.
- name: KCNQ3-BFNS
  display_name: KCNQ3-related benign familial neonatal seizures
  description: >-
    The less common molecular subtype, caused by heterozygous variants in
    KCNQ3 on chromosome 8q24.
  subtype_term:
    preferred_term: seizures, benign familial neonatal, 2
    term:
      id: MONDO:0007366
      label: seizures, benign familial neonatal, 2
  evidence:
  - reference: PMID:9425900
    reference_title: "A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We found a missense mutation in the critical pore region in perfect co-segregation with the BFNC phenotype."
    explanation: Charlier et al. 1998 identifies a KCNQ3 pore-region missense variant co-segregating with BFNC.
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "KCNQ3 | potassium voltage-gated channel subfamily Q member 3 | hgnc:6297 | Disease-causing germline mutation(s) in"
    explanation: Orphanet identifies KCNQ3 as a disease-causing gene for self-limited neonatal epilepsy.
progression:
- phase: Neonatal seizure onset
  age_range: First week of life
  notes: >-
    Seizures characteristically begin in the first days to first week of life
    in an otherwise well-appearing term infant.
  evidence:
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Age of onset: Neonatal"
    explanation: Orphanet's natural-history section classifies onset as neonatal.
  - reference: PMID:36939707
    reference_title: "ILAE Genetic Literacy Series: Self-limited familial epilepsy syndromes with onset in neonatal age and infancy."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "autosomal dominant disorders characterized by neonatal- or infantile-onset focal motor seizures and the absence of neurodevelopmental complications."
    explanation: The ILAE Genetics Commission review summarizes neonatal/infantile onset of focal motor seizures.
- phase: Spontaneous remission
  age_range: Within first year of life
  notes: >-
    Seizures characteristically remit during infancy or early childhood, hence
    the "self-limited" designation; long-term neurodevelopment is generally
    normal.
  evidence:
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "seizures onset typically in the first week of life, in otherwise healthy newborns, and usually resolving within the first year of life."
    explanation: Orphanet definition supports first-week onset and resolution within the first year.
  - reference: PMID:36939707
    reference_title: "ILAE Genetic Literacy Series: Self-limited familial epilepsy syndromes with onset in neonatal age and infancy."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: 'Seizures tend to remit during infancy or early childhood and are therefore called "self-limited".'
    explanation: ILAE literacy review supports spontaneous remission in infancy/early childhood.
- phase: Later seizure susceptibility
  age_range: Later childhood through adulthood
  notes: >-
    The neonatal epilepsy is self-limited, but later seizures can occur.
    GeneReviews estimates that about 30% of individuals with KCNQ2-related
    self-limited familial neonatal epilepsy develop epileptic seizures later in
    life; this estimate should not be generalized automatically to KCNQ3.
  evidence:
  - reference: PMID:20437616
    reference_title: "KCNQ2-Related Disorders."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "About 30% of individuals with KCNQ2-SLFNE develop epileptic seizures later in life."
    explanation: GeneReviews directly quantifies later seizure risk in the KCNQ2-related subtype.
genetic:
- name: KCNQ2
  association: Causal heterozygous pathogenic variant
  gene_term:
    preferred_term: KCNQ2
    term:
      id: hgnc:6296
      label: KCNQ2
  notes: >-
    KCNQ2 encodes the Kv7.2 voltage-gated potassium channel subunit on
    chromosome 20q13. Haploinsufficiency and other comparatively mild
    loss-of-function alleles commonly produce the self-limited phenotype, but
    variant class alone is not deterministic. A 2026 cohort associated
    single-allele truncating/NMD lesions and C-terminal or other
    nontransmembrane variants with SeL(F)NE, whereas transmembrane missense
    variants, especially in S5-pore-S6, were enriched in KCNQ2-DEE.
  inheritance:
  - name: Autosomal dominant with incomplete penetrance
    inheritance_term:
      preferred_term: Autosomal dominant inheritance
      term:
        id: HP:0000006
        label: Autosomal dominant inheritance
    penetrance: INCOMPLETE
    description: >-
      KCNQ2-related benign familial neonatal seizures show autosomal dominant
      inheritance with incomplete penetrance.
    evidence:
    - reference: PMID:36939707
      reference_title: "ILAE Genetic Literacy Series: Self-limited familial epilepsy syndromes with onset in neonatal age and infancy."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "incomplete penetrance and de novo inheritance occur"
      explanation: The ILAE Genetics Commission review documents incomplete penetrance across self-limited familial neonatal/infantile epilepsies.
  evidence:
  - reference: PMID:9425895
    reference_title: "A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Five other BFNC probands were shown to have KCNQ2 mutations, including two transmembrane missense mutations, two frameshifts and one splice-site mutation."
    explanation: Singh et al. 1998 established KCNQ2 as the major causal gene for benign familial neonatal convulsions.
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "KCNQ2 | potassium voltage-gated channel subfamily Q member 2 | hgnc:6296 | Disease-causing germline mutation(s) in"
    explanation: Orphanet gene table confirms KCNQ2 as a disease-causing gene.
  - reference: PMID:41988220
    reference_title: "KCNQ2 Variants in Neonatal Epilepsy: Clinical Characteristics and Neurodevelopmental Outcomes in 30 Patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Clear topology-phenotype patterns emerged: transmembrane missense variants-especially S5-pore-S6-were enriched in DEE, whereas C-terminal/nontransmembrane variants were associated with SeL(F)NE and benign outcomes."
    explanation: The cohort supports a topology-associated severity gradient while not making the association deterministic for an individual variant.
  - reference: PMID:41988220
    reference_title: "KCNQ2 Variants in Neonatal Epilepsy: Clinical Characteristics and Neurodevelopmental Outcomes in 30 Patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All 5 single-allele truncating/NMD lesions (CNV deletion, canonical splice-site, 2 nonsense, 1 frameshift) aligned with SeL(F)NE"
    explanation: All five single-allele truncating/NMD lesions in this cohort occurred in the self-limited group.
- name: KCNQ3
  association: Causal heterozygous pathogenic variant
  gene_term:
    preferred_term: KCNQ3
    term:
      id: hgnc:6297
      label: KCNQ3
  notes: >-
    KCNQ3 encodes the Kv7.3 voltage-gated potassium channel subunit on
    chromosome 8q24, which heteromultimerizes with Kv7.2 to form the neuronal
    M-channel. Heterozygous variants in KCNQ3 are a less common cause of
    benign familial neonatal seizures.
  inheritance:
  - name: Autosomal dominant with incomplete penetrance
    inheritance_term:
      preferred_term: Autosomal dominant inheritance
      term:
        id: HP:0000006
        label: Autosomal dominant inheritance
    penetrance: INCOMPLETE
    description: >-
      KCNQ3-related benign familial neonatal seizures show autosomal dominant
      inheritance with incomplete penetrance.
    evidence:
    - reference: PMID:36939707
      reference_title: "ILAE Genetic Literacy Series: Self-limited familial epilepsy syndromes with onset in neonatal age and infancy."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "incomplete penetrance and de novo inheritance occur"
      explanation: The ILAE Genetics Commission review documents incomplete penetrance across self-limited familial neonatal/infantile epilepsies.
  evidence:
  - reference: PMID:9425900
    reference_title: "A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We screened KCNQ3 for mutations in the large BFNC family previously linked to chromosome 8q24 in the same marker interval. We found a missense mutation in the critical pore region in perfect co-segregation with the BFNC phenotype."
    explanation: Charlier et al. 1998 established KCNQ3 as a causal BFNC gene.
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "KCNQ3 | potassium voltage-gated channel subfamily Q member 3 | hgnc:6297 | Disease-causing germline mutation(s) in"
    explanation: Orphanet gene table confirms KCNQ3 as a disease-causing gene.
pathophysiology:
- name: KCNQ2 Pathogenic Variant
  description: >-
    A heterozygous pathogenic KCNQ2 variant is the more common initiating
    lesion in self-limited familial neonatal epilepsy. Mild loss-of-function
    or haploinsufficiency is typical of the self-limited end of the spectrum,
    although variant class alone does not determine clinical severity.
  role: trigger
  gene:
    preferred_term: KCNQ2
    term:
      id: hgnc:6296
      label: KCNQ2
  evidence:
  - reference: PMID:9425895
    reference_title: "A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Five other BFNC probands were shown to have KCNQ2 mutations, including two transmembrane missense mutations, two frameshifts and one splice-site mutation."
    explanation: The original discovery series identifies heterozygous KCNQ2 variants as initiating lesions in BFNC.
  downstream:
  - target: Kv7.2/Kv7.3 M-Channel Dysfunction
    causal_link_type: DIRECT
    description: Pathogenic KCNQ2 variants impair Kv7.2-containing neuronal M channels.
    evidence:
    - reference: PMID:18483067
      reference_title: "Mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions show seizures and neuronal plasticity without synaptic reorganization."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Both Kcnq2(A306T/A306T) and Kcnq3(G311V/G311V) homozygous mutant mice exhibited early onset spontaneous generalized tonic-clonic seizures concurrent with a significant reduction in amplitude and increased deactivation kinetics of the neuronal M-current."
      explanation: The Kcnq2 BFNC-allele knock-in directly links the pathogenic variant to reduced and kinetically altered M-current.
- name: KCNQ3 Pathogenic Variant
  description: >-
    A heterozygous pathogenic KCNQ3 variant is a less common alternative
    initiating lesion in self-limited familial neonatal epilepsy. The original
    BFNC family carried a pore-region missense variant that co-segregated with
    the phenotype.
  role: trigger
  gene:
    preferred_term: KCNQ3
    term:
      id: hgnc:6297
      label: KCNQ3
  evidence:
  - reference: PMID:9425900
    reference_title: "A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We found a missense mutation in the critical pore region in perfect co-segregation with the BFNC phenotype."
    explanation: The original family establishes a heterozygous KCNQ3 pore variant as an alternative BFNC lesion.
  downstream:
  - target: Kv7.2/Kv7.3 M-Channel Dysfunction
    causal_link_type: DIRECT
    description: Pathogenic KCNQ3 variants impair Kv7.3-containing neuronal M channels.
    evidence:
    - reference: PMID:18483067
      reference_title: "Mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions show seizures and neuronal plasticity without synaptic reorganization."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Both Kcnq2(A306T/A306T) and Kcnq3(G311V/G311V) homozygous mutant mice exhibited early onset spontaneous generalized tonic-clonic seizures concurrent with a significant reduction in amplitude and increased deactivation kinetics of the neuronal M-current."
      explanation: The Kcnq3 BFNC-allele knock-in directly links the pathogenic variant to reduced and kinetically altered M-current.
- name: Kv7.2/Kv7.3 M-Channel Dysfunction
  description: >-
    KCNQ2 (Kv7.2) and KCNQ3 (Kv7.3) subunits co-assemble in the neuronal
    M channel. Pathogenic variants compromise this voltage-gated potassium
    channel complex and reduce or alter its current. This node captures the
    channel defect separately from its effect on neuronal excitability.
  role: mediator
  conforms_to: "epilepsy_excitation_inhibition_imbalance#Ion Channel and Synaptic Dysfunction"
  genes:
  - preferred_term: KCNQ2
    term:
      id: hgnc:6296
      label: KCNQ2
  - preferred_term: KCNQ3
    term:
      id: hgnc:6297
      label: KCNQ3
  cell_types:
  - preferred_term: neuron
    term:
      id: CL:0000540
      label: neuron
  molecular_functions:
  - preferred_term: voltage-gated potassium channel activity
    term:
      id: GO:0005249
      label: voltage-gated potassium channel activity
    modifier: DECREASED
  locations:
  - preferred_term: cerebral cortex
    term:
      id: UBERON:0000956
      label: cerebral cortex
  evidence:
  - reference: PMID:9836639
    reference_title: "KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "It is concluded that both these subunits contribute to the native M-current."
    explanation: Wang et al. 1998 directly demonstrates that KCNQ2 and KCNQ3 subunits constitute the M-channel.
  - reference: PMID:18483067
    reference_title: "Mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions show seizures and neuronal plasticity without synaptic reorganization."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Both Kcnq2(A306T/A306T) and Kcnq3(G311V/G311V) homozygous mutant mice exhibited early onset spontaneous generalized tonic-clonic seizures concurrent with a significant reduction in amplitude and increased deactivation kinetics of the neuronal M-current."
    explanation: Knock-in models of both human BFNC alleles directly demonstrate reduced and kinetically altered M-current.
  downstream:
  - target: Loss of M-Current Control of Neuronal Excitability
    causal_link_type: DIRECT
    description: Dysfunction of Kv7.2/Kv7.3 channels attenuates neuronal M-current.
    evidence:
    - reference: PMID:18483067
      reference_title: "Mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions show seizures and neuronal plasticity without synaptic reorganization."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Both Kcnq2(A306T/A306T) and Kcnq3(G311V/G311V) homozygous mutant mice exhibited early onset spontaneous generalized tonic-clonic seizures concurrent with a significant reduction in amplitude and increased deactivation kinetics of the neuronal M-current."
      explanation: Both mutant-channel models show reduced M-current amplitude and altered deactivation kinetics.
- name: Loss of M-Current Control of Neuronal Excitability
  description: >-
    The slowly activating, non-inactivating M-current operates in the
    subthreshold voltage range and restrains repetitive neuronal firing.
    Reduced M-current removes this stabilizing control of membrane potential.
  role: mediator
  cell_types:
  - preferred_term: neuron
    term:
      id: CL:0000540
      label: neuron
  biological_processes:
  - preferred_term: regulation of membrane potential
    term:
      id: GO:0042391
      label: regulation of membrane potential
    modifier: DYSREGULATED
  evidence:
  - reference: PMID:9836639
    reference_title: "KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "The M-current regulates the subthreshold electrical excitability of many neurons, determining their firing properties and responsiveness to synaptic input."
    explanation: The functional study establishes M-current as a regulator of subthreshold neuronal excitability.
  downstream:
  - target: Neonatal Neuronal Hyperexcitability
    causal_link_type: DIRECT
    description: Loss of the M-current brake permits excessive repetitive neuronal firing.
    evidence:
    - reference: PMID:9836639
      reference_title: "KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "The M-current regulates the subthreshold electrical excitability of many neurons, determining their firing properties and responsiveness to synaptic input."
      explanation: M-current regulation of firing provides the mechanistic link from current attenuation to hyperexcitability.
- name: Neonatal Neuronal Hyperexcitability
  description: >-
    Reduced M-current produces excessive firing and hypersynchronous activity
    in neonatal neuronal networks. The human mechanism of remission is not
    established. A 2026 Kcnq2 model study found timely recovery of excitability
    in a SeLNE model but delayed recovery in a DEE model, making age-limited
    recovery a supported animal-model result rather than a settled human
    mechanism.
  role: central_effector
  conforms_to: "epilepsy_excitation_inhibition_imbalance#Neuronal Hyperexcitability and Hypersynchrony"
  cell_types:
  - preferred_term: neuron
    term:
      id: CL:0000540
      label: neuron
  - preferred_term: pyramidal neuron
    term:
      id: CL:0000598
      label: pyramidal neuron
  biological_processes:
  - preferred_term: neuronal action potential
    term:
      id: GO:0019228
      label: neuronal action potential
    modifier: INCREASED
  locations:
  - preferred_term: cerebral cortex
    term:
      id: UBERON:0000956
      label: cerebral cortex
  evidence:
  - reference: PMID:36939707
    reference_title: "ILAE Genetic Literacy Series: Self-limited familial epilepsy syndromes with onset in neonatal age and infancy."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: 'Seizures tend to remit during infancy or early childhood and are therefore called "self-limited".'
    explanation: The ILAE review confirms the transient, age-limited nature of the seizure phenotype.
  - reference: PMID:41051877
    reference_title: Delayed excitability recovery and downregulation of neurodevelopmental pathways contribute to phenotypic differences in KCNQ2-related disorders.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Notably, whereas SeLNE mice showed timely recovery of excitability, DEE mice displayed delayed restoration of abnormal excitability in CA1 excitatory neurons."
    explanation: The paired mouse models support developmentally timed excitability recovery as a candidate explanation for phenotypic divergence.
  downstream:
  - target: Neonatal Focal Seizure Generation
    causal_link_type: DIRECT
    description: Developmentally restricted neuronal hyperexcitability generates focal neonatal seizures.
    evidence:
    - reference: PMID:41051877
      reference_title: Delayed excitability recovery and downregulation of neurodevelopmental pathways contribute to phenotypic differences in KCNQ2-related disorders.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "This study identifies that the age-related spontaneous remission of seizures is due to time-limited changes in neuronal excitability"
      explanation: The paired Kcnq2 models directly connect the time course of neuronal excitability to seizure remission.
- name: Neonatal Focal Seizure Generation
  description: >-
    Hyperexcitable neonatal networks generate recurrent focal seizures with
    tonic, clonic, and autonomic manifestations. This node separates seizure
    generation from the individual clinical semiologies and from the EEG
    pattern that reports the ictal activity.
  role: effector
  conforms_to: "epilepsy_excitation_inhibition_imbalance#Seizure Generation and Epileptogenesis"
  cell_types:
  - preferred_term: neuron
    term:
      id: CL:0000540
      label: neuron
  locations:
  - preferred_term: cerebral cortex
    term:
      id: UBERON:0000956
      label: cerebral cortex
  evidence:
  - reference: PMID:20437616
    reference_title: "KCNQ2-Related Disorders."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "video EEG identifies seizures as focal onset with tonic stiffening of limb(s) and some migration during each seizure's evolution."
    explanation: GeneReviews documents the focal neonatal seizure pattern and its tonic, migrating semiology.
  downstream:
  - target: Neonatal Seizure
    causal_link_type: DIRECT
    description: The hyperexcitable neonatal network state manifests as neonatal seizures.
    evidence:
    - reference: ORPHA:1949
      reference_title: "Self-limited neonatal epilepsy"
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "HP:0032807 | Neonatal seizure | Very frequent (99-80%)"
      explanation: Orphanet anchors neonatal seizures as a very frequent downstream manifestation of the curated syndrome.
  - target: Focal-onset Seizure
    causal_link_type: DIRECT
    description: Network-level hyperexcitability manifests as focal neonatal seizures.
    evidence:
    - reference: PMID:20437616
      reference_title: "KCNQ2-Related Disorders."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "video EEG identifies seizures as focal onset with tonic stiffening of limb(s) and some migration during each seizure's evolution."
      explanation: GeneReviews anchors focal onset as the characteristic electroclinical manifestation of KCNQ2-SLFNE.
  - target: Focal Tonic Seizure
    causal_link_type: DIRECT
    description: Neonatal network hyperexcitability can present with focal tonic semiology.
    evidence:
    - reference: PMID:20437616
      reference_title: "KCNQ2-Related Disorders."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "video EEG identifies seizures as focal onset with tonic stiffening of limb(s) and some migration during each seizure's evolution."
      explanation: GeneReviews directly describes the focal tonic semiology.
  - target: Focal Clonic Seizure
    causal_link_type: DIRECT
    description: Neonatal network hyperexcitability can present with focal clonic motor semiology.
    evidence:
    - reference: ORPHA:1949
      reference_title: "Self-limited neonatal epilepsy"
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "HP:0002266 | Focal clonic seizure | Very frequent (99-80%)"
      explanation: Orphanet anchors focal clonic seizures as a very frequent downstream manifestation.
  - target: Generalized Tonic Seizure
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - focal seizure propagation
    description: Focal neonatal seizures can secondarily generalize into tonic seizures.
    evidence:
    - reference: ORPHA:1949
      reference_title: "Self-limited neonatal epilepsy"
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "HP:0010818 | Generalized tonic seizure | Frequent (79-30%)"
      explanation: Orphanet anchors generalized tonic seizures as a frequent downstream manifestation.
  - target: Focal Autonomic Seizure
    causal_link_type: DIRECT
    description: Focal neonatal seizures can include autonomic features.
    evidence:
    - reference: ORPHA:1949
      reference_title: "Self-limited neonatal epilepsy"
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "HP:0011154 | Focal autonomic seizure | Frequent (79-30%)"
      explanation: Orphanet anchors focal autonomic seizures as a frequent downstream manifestation.
  - target: Apnea
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - ictal autonomic involvement
    description: Ictal autonomic involvement can produce apnea during neonatal seizures.
    evidence:
    - reference: PMID:20437616
      reference_title: "KCNQ2-Related Disorders."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "Seizures are characterized by sudden onset with prominent motor involvement, often accompanied by apnea and cyanosis"
      explanation: GeneReviews directly identifies apnea as an accompanying ictal manifestation.
  - target: Circumoral Cyanosis
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - ictal apnea
    - oxygen desaturation
    description: Apneic ictal events can produce circumoral cyanosis.
    evidence:
    - reference: PMID:20437616
      reference_title: "KCNQ2-Related Disorders."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "Seizures are characterized by sudden onset with prominent motor involvement, often accompanied by apnea and cyanosis"
      explanation: GeneReviews directly identifies cyanosis as an accompanying ictal manifestation.
  - target: Clonus
    causal_link_type: DIRECT
    description: Hyperexcitable neonatal motor networks produce clonic movements.
    evidence:
    - reference: ORPHA:1949
      reference_title: "Self-limited neonatal epilepsy"
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "HP:0002169 | Clonus | Frequent (79-30%)"
      explanation: Orphanet anchors clonus as a frequent downstream manifestation.
  - target: Limb Myoclonus
    causal_link_type: DIRECT
    description: Hyperexcitable neonatal motor networks can produce limb myoclonic jerks.
    evidence:
    - reference: ORPHA:1949
      reference_title: "Self-limited neonatal epilepsy"
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "HP:0045084 | Limb myoclonus | Frequent (79-30%)"
      explanation: Orphanet anchors limb myoclonus as a frequent downstream manifestation.
phenotypes:
- category: Neurologic
  name: Neonatal Seizure
  description: >-
    Seizures with neonatal onset are the defining clinical feature; first
    seizures typically occur within the first week of life.
  frequency: VERY_FREQUENT
  diagnostic: true
  phenotype_term:
    preferred_term: Neonatal seizure
    term:
      id: HP:0032807
      label: Neonatal seizure
  evidence:
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0032807 | Neonatal seizure | Very frequent (99-80%)"
    explanation: Orphanet's curated HPO table classifies neonatal seizures as very frequent.
  - reference: PMID:36939707
    reference_title: "ILAE Genetic Literacy Series: Self-limited familial epilepsy syndromes with onset in neonatal age and infancy."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "autosomal dominant disorders characterized by neonatal- or infantile-onset focal motor seizures and the absence of neurodevelopmental complications."
    explanation: ILAE review supports neonatal-onset focal motor seizures as the defining feature.
- category: Neurologic
  name: Focal-onset Seizure
  description: >-
    Seizures are typically focal in onset, often with tonic or clonic motor
    features and may secondarily generalize.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Focal-onset seizure
    term:
      id: HP:0007359
      label: Focal-onset seizure
  evidence:
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0007359 | Focal-onset seizure | Very frequent (99-80%)"
    explanation: Orphanet's curated HPO table classifies focal-onset seizures as very frequent.
- category: Neurologic
  name: Focal Tonic Seizure
  description: >-
    Brief focal tonic seizures, often with apnea and desaturation, are a
    characteristic ictal semiology in KCNQ2/KCNQ3 neonatal epilepsy.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Focal tonic seizure
    term:
      id: HP:0011167
      label: Focal tonic seizure
  evidence:
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0011167 | Focal tonic seizure | Very frequent (99-80%)"
    explanation: Orphanet's curated HPO table classifies focal tonic seizures as very frequent.
  - reference: PMID:28926830
    reference_title: A Distinctive Ictal Amplitude-Integrated Electroencephalography Pattern in Newborns with Neonatal Epilepsy Associated with KCNQ2 Mutations.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Refractory seizures occurred in the early neonatal period with similar seizure type, including tonic features, apnea, and desaturation."
    explanation: KCNQ2 case series describes characteristic tonic seizures with apnea/desaturation.
- category: Neurologic
  name: Focal Clonic Seizure
  description: >-
    Focal clonic seizures, classically migrating between limbs and hemispheres,
    are commonly observed.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Focal clonic seizure
    term:
      id: HP:0002266
      label: Focal clonic seizure
  evidence:
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0002266 | Focal clonic seizure | Very frequent (99-80%)"
    explanation: Orphanet's curated HPO table classifies focal clonic seizures as very frequent.
- category: Neurologic
  name: Apnea
  description: >-
    Apnea and cyanosis frequently accompany ictal events in neonatal KCNQ2/3
    epilepsy.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Apnea
    term:
      id: HP:0002104
      label: Apnea
  evidence:
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0002104 | Apnea | Frequent (79-30%)"
    explanation: Orphanet's curated HPO table classifies apnea as frequent.
  - reference: PMID:28926830
    reference_title: A Distinctive Ictal Amplitude-Integrated Electroencephalography Pattern in Newborns with Neonatal Epilepsy Associated with KCNQ2 Mutations.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Refractory seizures occurred in the early neonatal period with similar seizure type, including tonic features, apnea, and desaturation."
    explanation: KCNQ2 case series documents ictal apnea as a recurrent feature.
- category: Neurologic
  name: Clonus
  description: >-
    Clonic motor features occur at frequent rate in neonates with KCNQ2/KCNQ3-related
    epilepsy.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Clonus
    term:
      id: HP:0002169
      label: Clonus
  evidence:
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0002169 | Clonus | Frequent (79-30%)"
    explanation: Orphanet's curated HPO table classifies clonus as frequent.
- category: Neurologic
  name: Generalized Tonic Seizure
  description: >-
    Tonic seizures with secondary generalization occur at frequent rate in neonates
    with KCNQ2/KCNQ3-related epilepsy, distinct from the focal tonic semiology that
    dominates initial presentations.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Generalized tonic seizure
    term:
      id: HP:0010818
      label: Generalized tonic seizure
  evidence:
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0010818 | Generalized tonic seizure | Frequent (79-30%)"
    explanation: Orphanet's curated HPO table classifies generalized tonic seizures as frequent.
- category: Neurologic
  name: Focal Autonomic Seizure
  description: >-
    Focal seizures with autonomic features (e.g., apnea, cyanosis, heart-rate
    changes) occur at frequent rate in KCNQ2/KCNQ3-related neonatal epilepsy.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Focal autonomic seizure
    term:
      id: HP:0011154
      label: Focal autonomic seizure
  evidence:
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0011154 | Focal autonomic seizure | Frequent (79-30%)"
    explanation: Orphanet's curated HPO table classifies focal autonomic seizures as frequent.
- category: Neurologic
  name: Circumoral Cyanosis
  description: >-
    Circumoral cyanosis accompanies ictal events at frequent rate, reflecting
    apneic and autonomic involvement in KCNQ2/KCNQ3-related neonatal seizures.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Circumoral cyanosis
    term:
      id: HP:0032556
      label: Circumoral cyanosis
  evidence:
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0032556 | Circumoral cyanosis | Frequent (79-30%)"
    explanation: Orphanet's curated HPO table classifies circumoral cyanosis as frequent.
- category: Neurologic
  name: Limb Myoclonus
  description: >-
    Myoclonic jerks of the limbs occur at frequent rate in neonates with
    KCNQ2/KCNQ3-related epilepsy, distinct from focal clonic semiology.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Limb myoclonus
    term:
      id: HP:0045084
      label: Limb myoclonus
  evidence:
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0045084 | Limb myoclonus | Frequent (79-30%)"
    explanation: Orphanet's curated HPO table classifies limb myoclonus as frequent.
- category: Neurologic
  name: Focal EEG Discharges with Secondary Generalization
  description: >-
    Interictal EEG can show focal epileptiform discharges associated with the
    focal seizure-generating network.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Focal EEG discharges with secondary generalization
    term:
      id: HP:0011188
      label: Focal EEG discharges with secondary generalization
  electrophysiology:
    electrophysiology_modality: EEG
    ictal_state: INTERICTAL
  reports_on:
  - target: Neonatal Focal Seizure Generation
    relationship: READOUT_OF
    direction: POSITIVE
    endpoint_context: DIAGNOSTIC
    interpretation: >-
      The interictal EEG finding is an observational readout of the focal
      neonatal seizure-generating network, not a downstream causal event.
  evidence:
  - reference: ORPHA:1949
    reference_title: "Self-limited neonatal epilepsy"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0011188 | Focal EEG discharges with secondary generalization | Very frequent (99-80%)"
    explanation: Orphanet's curated HPO table classifies this EEG pattern as very frequent.
diagnosis:
- name: KCNQ2/KCNQ3 molecular genetic testing
  description: >-
    Targeted KCNQ2/KCNQ3 sequencing or epilepsy gene-panel/whole-exome
    sequencing identifies pathogenic variants. Molecular results must be
    interpreted with the neonatal phenotype and EEG because KCNQ2 variants span
    self-limited epilepsy and KCNQ2-DEE.
  diagnosis_term:
    preferred_term: molecular genetic testing
    term:
      id: NCIT:C19770
      label: Molecular Analysis
  results: Heterozygous pathogenic or likely pathogenic variants in KCNQ2 or KCNQ3 support the diagnosis.
  evidence:
  - reference: PMID:20437616
    reference_title: "KCNQ2-Related Disorders."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "The diagnosis of a KCNQ2-related disorder is established in a proband with suggestive findings and a heterozygous pathogenic variant in KCNQ2 identified by molecular genetic testing."
    explanation: GeneReviews requires both compatible findings and a heterozygous pathogenic KCNQ2 variant.
  - reference: PMID:36939707
    reference_title: "ILAE Genetic Literacy Series: Self-limited familial epilepsy syndromes with onset in neonatal age and infancy."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "we describe important clues in recognition of these syndromes, diagnostic steps including genetic testing, management, and genetic counseling."
    explanation: ILAE Genetics Commission supports genetic testing as part of the diagnostic workup.
- name: Amplitude-integrated EEG (aEEG)
  description: >-
    Amplitude-integrated EEG can capture a distinctive ictal pattern in
    some neonates with KCNQ2/3 variants, allowing early electroclinical
    recognition while molecular results are pending. The published evidence is
    from small retrospective case series across the KCNQ2/3 neonatal epilepsy
    spectrum, not a validated test specific to SeL(F)NE.
  diagnosis_term:
    preferred_term: electroencephalography
    term:
      id: NCIT:C38054
      label: Electroencephalography
  results: A sudden rise in both aEEG margins followed by marked amplitude depression is a reported ictal pattern that may prompt KCNQ2/KCNQ3 testing and treatment consideration.
  evidence:
  - reference: PMID:28926830
    reference_title: A Distinctive Ictal Amplitude-Integrated Electroencephalography Pattern in Newborns with Neonatal Epilepsy Associated with KCNQ2 Mutations.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A distinct aEEG seizure pattern, consisting of a sudden rise of the lower and upper margin of the aEEG, followed by a marked depression of the aEEG amplitude, was found in 8 of the 9 patients."
    explanation: Multicenter case series defines a distinctive aEEG pattern in KCNQ2-related neonatal epilepsy.
  - reference: PMID:37827512
    reference_title: "Distinctive Amplitude-Integrated EEG Ictal Pattern and Targeted Therapy with Carbamazepine in KCNQ2 and KCNQ3 Neonatal Epilepsy: A Case Series."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Recognition of the distinctive ictal aEEG pattern in the NICU allowed early and effective targeted therapy with CBZ in four neonates, well before genetic results became available."
    explanation: A subsequent case series confirms aEEG pattern recognition enables early targeted therapy.
- name: Neonatal EEG background and neurologic examination
  description: >-
    Conventional EEG background and neonatal neurologic examination help
    distinguish a likely self-limited course from KCNQ2-DEE. Burst suppression,
    profound discontinuity, markedly abnormal background, or abnormal tone are
    red flags for adverse developmental outcome rather than defining features
    of SeL(F)NE.
  diagnosis_term:
    preferred_term: electroencephalography
    term:
      id: NCIT:C38054
      label: Electroencephalography
  results: A relatively preserved background and normal examination support the self-limited end; marked abnormalities require longitudinal developmental surveillance and reassessment for KCNQ2-DEE.
  evidence:
  - reference: PMID:41988220
    reference_title: "KCNQ2 Variants in Neonatal Epilepsy: Clinical Characteristics and Neurodevelopmental Outcomes in 30 Patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "burst-suppression/profound discontinuity consistently signaled adverse neurodevelopment."
    explanation: The 30-patient cohort links severely abnormal EEG background to adverse outcome.
  - reference: PMID:42081271
    reference_title: "KCNQ2 neonatal epilepsy: Impact of prompt diagnosis and treatment, and early predictors of outcome severity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Factors in the neonatal period associated with abnormal developmental outcome included neurological abnormalities (e.g., abnormal tone) and markedly abnormal neonatal EEG background"
    explanation: The multicenter cohort independently identifies examination and EEG-background red flags.
differential_diagnoses:
- name: KCNQ2 developmental and epileptic encephalopathy
  description: >-
    KCNQ2-DEE can begin in the same first postnatal week and share focal tonic
    seizures, but it represents the severe end of the KCNQ2 spectrum rather
    than the self-limited syndrome.
  disease_term:
    preferred_term: KCNQ2 developmental and epileptic encephalopathy
    term:
      id: MONDO:0013387
      label: developmental and epileptic encephalopathy, 7
  distinguishing_features:
  - Multiple daily or drug-resistant neonatal seizures
  - Burst-suppression, profound discontinuity, or multifocal epileptiform EEG background
  - Abnormal neurologic examination and moderate-to-profound developmental impairment
  - Transmembrane or pore-region missense variants are enriched but do not determine outcome alone
  evidence:
  - reference: PMID:20437616
    reference_title: "KCNQ2-Related Disorders."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "At onset, EEG shows a burst-suppression pattern or multifocal epileptiform activity; early brain MRI can show basal ganglia hyperdensities and later MRIs may show white matter or general volume loss. Moderate-to-profound developmental impairment is present."
    explanation: GeneReviews defines EEG, imaging, and developmental features that distinguish KCNQ2-NEO-DEE from KCNQ2-SLFNE.
  - reference: PMID:41988220
    reference_title: "KCNQ2 Variants in Neonatal Epilepsy: Clinical Characteristics and Neurodevelopmental Outcomes in 30 Patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Neurodevelopment was normal in 63%; delays occurred only within the DEE cohort."
    explanation: This cohort supports developmental delay as a boundary with the DEE subgroup.
- name: Benign familial infantile epilepsy
  description: >-
    Self-limited familial infantile epilepsy also causes autosomal dominant
    focal seizures with favorable development but begins in infancy rather than
    the characteristic neonatal window.
  disease_term:
    preferred_term: benign familial infantile epilepsy
    term:
      id: MONDO:0017615
      label: benign familial infantile epilepsy
  distinguishing_features:
  - Onset after the neonatal period, usually in infancy
  evidence:
  - reference: PMID:40236662
    reference_title: "Oxcarbazepine may be an effective option for Chinese pediatric patients with self-limited focal epilepsy of neonatal/infantile onset: a retrospective cohort study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "self-limited familial infantile epilepsy (SeLIE, 1 – 24 months)"
    explanation: The cohort review supplies the infantile age boundary used to distinguish SeLIE.
- name: Acute symptomatic neonatal seizures
  description: >-
    Hypoglycemia, hypocalcemia, intracranial infection, traumatic or structural
    brain injury, and other acute symptomatic etiologies can present with
    neonatal seizures and must be excluded before diagnosing a genetic
    self-limited epilepsy.
  distinguishing_features:
  - An identifiable metabolic, infectious, or acquired neurologic trigger
  - Seizure course follows the acute underlying condition rather than a familial self-limited epilepsy pattern
  evidence:
  - reference: PMID:40236662
    reference_title: "Oxcarbazepine may be an effective option for Chinese pediatric patients with self-limited focal epilepsy of neonatal/infantile onset: a retrospective cohort study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Children diagnosed with any of the following were excluded from the study: (1) pediatric malignancies, (2) hypoglycaemia, (3) intracranial infections, (4) traumatic brain injuries, (5) hypocalcemia, and (6) symptomatic epilepsy."
    explanation: The self-limited epilepsy cohort explicitly excluded common acute symptomatic and acquired causes.
treatments:
- name: Carbamazepine
  description: >-
    Carbamazepine, a sodium-channel-blocking antiseizure medication, is
    frequently reported to control KCNQ2/KCNQ3-related neonatal seizures.
    Support comes from small retrospective case series and a systematic review
    whose 29 included studies were all retrospective; it does not establish a
    randomized first-line superiority claim. Some infants with the
    self-limited phenotype also become seizure-free without treatment.
  treatment_term:
    preferred_term: anticonvulsant agent therapy
    term:
      id: NCIT:C64172
      label: Anticonvulsant Therapy
    therapeutic_agent:
    - preferred_term: carbamazepine
      term:
        id: CHEBI:3387
        label: carbamazepine
  target_phenotypes:
  - preferred_term: Neonatal seizure
    term:
      id: HP:0032807
      label: Neonatal seizure
  - preferred_term: Focal-onset seizure
    term:
      id: HP:0007359
      label: Focal-onset seizure
  evidence:
  - reference: PMID:37827512
    reference_title: "Distinctive Amplitude-Integrated EEG Ictal Pattern and Targeted Therapy with Carbamazepine in KCNQ2 and KCNQ3 Neonatal Epilepsy: A Case Series."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "prompted the use of CBZ that was effective in all."
    explanation: Carbamazepine was effective in all four neonates given the targeted therapy in this case series.
  - reference: PMID:28926830
    reference_title: A Distinctive Ictal Amplitude-Integrated Electroencephalography Pattern in Newborns with Neonatal Epilepsy Associated with KCNQ2 Mutations.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Prompt recognition of this pattern led to early treatment with carbamazepine in the 2 most recent cases."
    explanation: Earlier KCNQ2 case series also supports carbamazepine as targeted therapy.
  - reference: PMID:36948217
    reference_title: "KCNQ2-Related Epilepsy: Genotype-Phenotype Relationship with Tailored Antiseizure Medication (ASM)-A Systematic Review."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: 'CONCLUSION: Phenobarbital or carbamazepine appears to be the most effective antiseizure medication for children with a "benign" variant.'
    explanation: The systematic review supports carbamazepine as a commonly effective option while its retrospective evidence base limits causal ranking.
  - reference: PMID:20437616
    reference_title: "KCNQ2-Related Disorders."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Seizures are generally controlled with conventional anti-seizure medication (ASM), although a significant number of individuals experience seizure freedom spontaneously."
    explanation: GeneReviews supports both conventional treatment response and the possibility of spontaneous seizure freedom.
- name: Sodium-channel-blocking Antiseizure Medication Therapy
  description: >-
    Sodium-channel blockers as a class, including carbamazepine and
    oxcarbazepine in the cited cohorts, are often used as targeted therapy for
    KCNQ2/KCNQ3-related neonatal seizures. Recent cohorts associate early use
    or oxcarbazepine exposure with seizure control, but treatment selection was
    not randomized, the cohorts span both self-limited and DEE phenotypes, and
    developmental benefit has not been established.
  treatment_term:
    preferred_term: anticonvulsant agent therapy
    term:
      id: NCIT:C64172
      label: Anticonvulsant Therapy
    therapeutic_agent:
    - preferred_term: carbamazepine
      term:
        id: CHEBI:3387
        label: carbamazepine
    - preferred_term: oxcarbazepine
      term:
        id: CHEBI:7824
        label: oxcarbazepine
  target_phenotypes:
  - preferred_term: Neonatal seizure
    term:
      id: HP:0032807
      label: Neonatal seizure
  evidence:
  - reference: PMID:28926830
    reference_title: A Distinctive Ictal Amplitude-Integrated Electroencephalography Pattern in Newborns with Neonatal Epilepsy Associated with KCNQ2 Mutations.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Early recognition of the electroclinical phenotype by using aEEG may direct genetic testing and a precision medicine approach with sodium channel blockers in neonates with KCNQ2 mutations."
    explanation: The case series explicitly recommends sodium-channel blockers as targeted precision therapy in KCNQ2 neonatal epilepsy.
  - reference: PMID:40236662
    reference_title: "Oxcarbazepine may be an effective option for Chinese pediatric patients with self-limited focal epilepsy of neonatal/infantile onset: a retrospective cohort study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Among the 12 patients who failed to respond to the first monotherapy, 9 patients achieved a seizure free status with oxcarbazepine, which was used as the second-line monotherapy or as add-on therapy."
    explanation: A broader neonatal/infantile self-limited focal-epilepsy cohort reports oxcarbazepine-associated seizure freedom after initial monotherapy failure.
  - reference: PMID:41988220
    reference_title: "KCNQ2 Variants in Neonatal Epilepsy: Clinical Characteristics and Neurodevelopmental Outcomes in 30 Patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Oxcarbazepine was often associated with seizure control after phenobarbital nonresponse, but this observational signal should not be interpreted as causal."
    explanation: The KCNQ2 cohort reports the association and explicitly limits causal interpretation.
  - reference: PMID:42081271
    reference_title: "KCNQ2 neonatal epilepsy: Impact of prompt diagnosis and treatment, and early predictors of outcome severity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "However, a prospective, long-term study is needed to determine whether early treatment also improves developmental outcomes."
    explanation: The multicenter cohort expressly leaves developmental benefit unresolved.
animal_models:
- species: Mouse (Mus musculus)
  genotype: Kcnq2 A306T and Kcnq3 G311V knock-in lines
  genes:
  - preferred_term: KCNQ2
    term:
      id: hgnc:6296
      label: KCNQ2
  - preferred_term: KCNQ3
    term:
      id: hgnc:6297
      label: KCNQ3
  description: >-
    Heterozygous knock-in mice carrying human BFNC missense alleles show lower
    induced-seizure thresholds. Homozygous mice show reduced M-current and
    spontaneous seizures that persist into adulthood, reproducing channel
    dysfunction but not the human self-limited time course.
  associated_phenotypes:
  - Reduced neuronal M-current amplitude
  - Lower electrically induced seizure threshold
  - Early-onset spontaneous generalized tonic-clonic seizures in homozygous mice
  - Persistent adult seizures without hippocampal neuronal loss
  evidence:
  - reference: PMID:18483067
    reference_title: "Mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions show seizures and neuronal plasticity without synaptic reorganization."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Adult Kcnq2(A306T/+) and Kcnq3(G311V/+) heterozygous knock-in mice exhibited reduced thresholds to electrically induced seizures compared to wild-type littermate mice."
    explanation: The heterozygous lines reproduce increased seizure susceptibility.
  - reference: PMID:18483067
    reference_title: "Mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions show seizures and neuronal plasticity without synaptic reorganization."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Mice had recurrent seizures into adulthood that triggered molecular plasticity including ectopic neuropeptide Y (NPY) expression in granule cells, but without hippocampal mossy fibre sprouting or neuronal loss."
    explanation: The persistent adult-seizure course establishes an important mismatch with human remission.
- species: Mouse (Mus musculus)
  genes:
  - preferred_term: KCNQ2
    term:
      id: hgnc:6296
      label: KCNQ2
  description: >-
    Paired Kcnq2 models were studied from postnatal day 14 to 28 with brain-slice
    patch clamp and single-nucleus RNA sequencing. Both models were
    hyperexcitable, but the SeLNE model recovered excitability on time while
    the DEE model recovered later and showed different neurodevelopmental
    transcriptional programs.
  associated_phenotypes:
  - High-frequency action-potential firing
  - Timely recovery of excitability in the SeLNE model
  - Delayed excitability recovery in the DEE model
  evidence:
  - reference: PMID:41051877
    reference_title: Delayed excitability recovery and downregulation of neurodevelopmental pathways contribute to phenotypic differences in KCNQ2-related disorders.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Using brain slice patch-clamp and single-nucleus RNA sequencing, we revealed developmental dysregulation in two different phenotypic Kcnq2 mice (DEE vs. SeLNE) during postnatal days 14-28 (P14-P28)."
    explanation: The study defines the paired models, developmental interval, and measurement modalities.
  - reference: PMID:41051877
    reference_title: Delayed excitability recovery and downregulation of neurodevelopmental pathways contribute to phenotypic differences in KCNQ2-related disorders.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Notably, whereas SeLNE mice showed timely recovery of excitability, DEE mice displayed delayed restoration of abnormal excitability in CA1 excitatory neurons."
    explanation: The comparative result directly supports the age-limited recovery distinction.
experimental_models:
- name: Heterologous KCNQ2/KCNQ3 M-channel expression assay
  description: >-
    Heterologous expression of KCNQ2 and KCNQ3 subunits permits
    electrophysiologic and pharmacologic characterization of homomeric and
    heteromeric channels and links the two subunits to native neuronal
    M-current.
  experimental_model_type: OTHER
  conditions:
  - KCNQ2 expression
  - KCNQ3 expression
  - KCNQ2/KCNQ3 co-expression
  culture_system: Heterologous ion-channel expression with voltage-clamp characterization
  publication: PMID:9836639
  modeled_mechanisms:
  - target: Kv7.2/Kv7.3 M-Channel Dysfunction
    description: Assays the biophysical and pharmacologic properties of Kv7.2/Kv7.3 channels that constitute neuronal M-current.
    evidence:
    - reference: PMID:9836639
      reference_title: "KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "It is concluded that both these subunits contribute to the native M-current."
      explanation: The heterologous channel study directly links KCNQ2 and KCNQ3 subunits to the modeled M-current mechanism.
  evidence:
  - reference: PMID:9836639
    reference_title: "KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "The biophysical properties, sensitivity to pharmacological blockade, and expression pattern of the KCNQ2 and KCNQ3 potassium channels were determined."
    explanation: The study establishes the heterologous functional characterization used to identify the channel subunits.
  - reference: PMID:9836639
    reference_title: "KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "It is concluded that both these subunits contribute to the native M-current."
    explanation: The assay result links KCNQ2/KCNQ3 channel behavior to neuronal M-current.
datasets:
- accession: PMID:41988220
  title: "KCNQ2 Variants in Neonatal Epilepsy: Clinical Characteristics and Neurodevelopmental Outcomes in 30 Patients."
  description: >-
    Publication-level, two-center cohort integrating whole-exome sequencing,
    EEG, MRI, treatment, seizure-freedom, and developmental outcome data from
    30 neonates with KCNQ2 variants. It compares SeL(F)NE and DEE and therefore
    must be phenotype-stratified when used for this focal disease.
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  data_type: WES
  sample_count: 30
  conditions:
  - self-limited familial neonatal epilepsy
  - KCNQ2 developmental and epileptic encephalopathy
  genes:
  - preferred_term: KCNQ2
    term:
      id: hgnc:6296
      label: KCNQ2
  publication: PMID:41988220
  findings: []
  evidence:
  - reference: PMID:41988220
    reference_title: "KCNQ2 Variants in Neonatal Epilepsy: Clinical Characteristics and Neurodevelopmental Outcomes in 30 Patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We conducted a retrospective, two-center study of 30 neonates from 2019 to 2024. All patients underwent whole-exome sequencing with Sanger confirmation"
    explanation: The methods define the cohort size, ascertainment period, and sequencing basis.
  notes: >-
    No dedicated public repository accession was identified in this review;
    PMID:41988220 identifies the publication-level cohort.
clinical_trials:
- name: NCT05157737
  phase: NOT_APPLICABLE
  status: UNKNOWN
  description: >-
    Observational phenotype and omics study intended to build a KCNQ2-related
    epilepsy phenotype/sample resource, study genotype-phenotype association,
    analyze multimodal imaging and EEG brain networks, and seek prognostic
    biomarkers. It spans the broader KCNQ2 epilepsy spectrum and is not a
    SeL(F)NE-specific treatment trial.
  evidence:
  - reference: clinicaltrials:NCT05157737
    reference_title: Clinical Phenotype and Omics Study of KCNQ2-related Epilepsy
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The aims of study on KCNQ2-related epilepsy: (1) establish phenotype database and sample database of KCNQ2-related epilepsy; (2) to establish genotype-phenotype association of KCNQ2-related epilepsy; (3) to study the brain network of KCNQ2-related epilepsy based on multi-modal brain image and EEG data; (4) to find prognostic biomarkers of KCNQ2-related epilepsy based on omics study."
    explanation: The registry summary defines the study as a broad observational phenotype, imaging/EEG, and omics resource.
  review_notes: >-
    ClinicalTrials.gov listed recruitment status as unknown when checked on
    2026-07-23; the record was last updated in 2021.
discussions:
- discussion_id: gap_bfns_variant_class_severity_determinants
  prompt: >-
    Which molecular properties of a KCNQ2 or KCNQ3 variant (mild
    haploinsufficiency versus dominant-negative strong loss-of-function versus
    gain-of-function) determine whether it produces self-limiting benign
    familial neonatal seizures rather than the severe KCNQ2 developmental and
    epileptic encephalopathy, and can M-current openers be matched to variant
    class?
  kind: CONTROVERSY
  status: OPEN
  attaches_to:
  - pathophysiology#KCNQ2 Pathogenic Variant
  - pathophysiology#KCNQ3 Pathogenic Variant
  - pathophysiology#Kv7.2/Kv7.3 M-Channel Dysfunction
  rationale: >-
    The same gene produces strikingly different severity. Recent cohorts
    associate single-allele truncating/NMD and nontransmembrane variants with
    SeL(F)NE, and transmembrane or pore-region missense variants with DEE, but
    the evidence is retrospective and not deterministic for an individual
    variant. Functional mechanism, allelic context, and KCNQ3-specific evidence
    remain incomplete. This gap has therapeutic stakes because M-current
    openers and sodium-channel blockers may behave differently across
    loss-of-function, dominant-negative, and gain-of-function variants.
  evidence:
  - reference: PMID:22275249
    reference_title: "KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A few reports on patients with a KCNQ2 mutation with a more severe outcome exist, but a definite relationship has not been established."
    explanation: >-
      Weckhuysen et al. show that severe KCNQ2 outcomes were recognized before a
      definite genotype-severity relationship was established, framing the open
      question of what distinguishes benign from encephalopathic variants.
  - reference: PMID:41988220
    reference_title: "KCNQ2 Variants in Neonatal Epilepsy: Clinical Characteristics and Neurodevelopmental Outcomes in 30 Patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Clear topology-phenotype patterns emerged: transmembrane missense variants-especially S5-pore-S6-were enriched in DEE, whereas C-terminal/nontransmembrane variants were associated with SeL(F)NE and benign outcomes."
    explanation: >-
      This 30-patient cohort strengthens a topology-severity association but
      remains too small and observational to close the variant-level prediction
      question.
  proposed_experiments:
  - experiment_id: exp_bfns_variant_class_functional_panel
    name: KCNQ2/KCNQ3 variant-class functional and pharmacology panel
    description: >-
      Express matched benign-familial-neonatal-seizure and developmental and
      epileptic encephalopathy variants of KCNQ2 and KCNQ3 in a shared
      heterologous background, with and without co-expressed wild-type subunit,
      and measure M-current density, activation and deactivation kinetics,
      dominant-negative suppression, and pharmacological rescue by retigabine.
    experiment_type:
      preferred_term: heterologous channel electrophysiology and pharmacology experiment
    perturbations:
    - name: KCNQ2/KCNQ3 variant expression
      target: pathophysiology#Kv7.2/Kv7.3 M-Channel Dysfunction
      genes:
      - preferred_term: KCNQ2
        term:
          id: hgnc:6296
          label: KCNQ2
      - preferred_term: KCNQ3
        term:
          id: hgnc:6297
          label: KCNQ3
      description: >-
        Introduce individual benign and encephalopathy-associated variants,
        alone and co-expressed with wild-type subunit, to quantify variant-class
        effects on channel function.
    readouts:
    - name: M-current density and pharmacological rescue
      target: pathophysiology#Loss of M-Current Control of Neuronal Excitability
      biological_processes:
      - preferred_term: membrane repolarization
        term:
          id: GO:0086009
          label: membrane repolarization
        modifier: DECREASED
      assays:
      - preferred_term: patch-clamp electrophysiology assay
      direction: POSITIVE
    controls:
    - name: Wild-type channel
      description: Wild-type KCNQ2/KCNQ3 heteromeric channels.
    - name: Benign versus encephalopathy variant comparison
      description: Matched benign and encephalopathy variants assayed in the same background.
    decision_criterion: >-
      A variant-class-to-severity model is supported if encephalopathy variants
      reproducibly cause stronger M-current suppression or dominant-negative
      behaviour than benign variants, and if retigabine rescue differs
      predictably by class.
    would_support:
    - pathophysiology#KCNQ2 Pathogenic Variant
    - pathophysiology#KCNQ3 Pathogenic Variant
    - pathophysiology#Kv7.2/Kv7.3 M-Channel Dysfunction
    - pathophysiology#Loss of M-Current Control of Neuronal Excitability

- discussion_id: gap_bfns_self_limiting_developmental_basis
  prompt: >-
    What developmental changes drive the spontaneous remission of benign
    familial neonatal seizures within the first months of life, given that the
    mutant KCNQ2/KCNQ3 channel continues to be expressed throughout adulthood?
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - pathophysiology#Neonatal Neuronal Hyperexcitability
  rationale: >-
    Seizures remit despite lifelong expression of the causal variant, so
    remission cannot be explained by loss of the mutant channel. A 2026 paired
    mouse-model study found timely excitability recovery and activation of
    neurodevelopmental signaling in the SeLNE model, whereas recovery was
    delayed in the DEE model. The responsible cell programs and their fidelity
    to human remission remain unresolved, as do the possible contributions of
    compensatory potassium conductances, chloride homeostasis, and inhibitory
    circuit maturation.
  evidence:
  - reference: PMID:18483067
    reference_title: "Mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions show seizures and neuronal plasticity without synaptic reorganization."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "exhibits the remarkable feature of clinical remission within a few weeks of onset and a favourable prognosis, sparing cognitive abilities despite persistent expression of the mutant KCNQ2 or KCNQ3 potassium channels throughout adulthood."
    explanation: >-
      Singh et al. frame the paradox directly: remission occurs despite
      persistent expression of the mutant channel, motivating a developmental
      rather than channel-loss explanation.
  - reference: PMID:36939707
    reference_title: "ILAE Genetic Literacy Series: Self-limited familial epilepsy syndromes with onset in neonatal age and infancy."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: 'Seizures tend to remit during infancy or early childhood and are therefore called "self-limited".'
    explanation: >-
      The ILAE review documents the self-limited course whose developmental
      basis this gap seeks to explain.
  - reference: PMID:41051877
    reference_title: Delayed excitability recovery and downregulation of neurodevelopmental pathways contribute to phenotypic differences in KCNQ2-related disorders.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Conversely, SeLNE mice exhibited pronounced activation of neurodevelopmental signaling pathways."
    explanation: >-
      The paired mouse study supplies a specific developmental signal but does
      not identify which program is necessary for human remission.
  proposed_experiments:
  - experiment_id: exp_bfns_developmental_timecourse
    name: Developmental time-course of excitability and chloride homeostasis
    description: >-
      In patient-derived iPSC cortical neurons and in Kcnq2/Kcnq3 knock-in mice,
      map M-current density, KCC2 expression, GABA reversal potential, and
      network excitability across the equivalent postnatal maturation window to
      identify which change coincides with seizure remission.
    experiment_type:
      preferred_term: developmental time-course electrophysiology experiment
    readouts:
    - name: Maturation of excitability and inhibition
      target: pathophysiology#Neonatal Neuronal Hyperexcitability
      biological_processes:
      - preferred_term: membrane repolarization
        term:
          id: GO:0086009
          label: membrane repolarization
        modifier: DECREASED
      - preferred_term: trans-synaptic signaling
        term:
          id: GO:0099537
          label: trans-synaptic signaling
        modifier: DYSREGULATED
      assays:
      - preferred_term: patch-clamp electrophysiology assay
      - preferred_term: multielectrode array recording
      direction: POSITIVE
    controls:
    - name: Isogenic corrected neurons
      description: Neurons in which the KCNQ2/KCNQ3 variant is corrected.
    - name: Wild-type littermate mice
      description: Age-matched wild-type mice for the developmental time-course.
    decision_criterion: >-
      A developmental driver of remission is supported if a specific maturational
      change (compensatory K+ conductance, KCC2/chloride switch, or inhibitory
      maturation) reproducibly coincides with the normalization of network
      excitability despite continued mutant-channel expression.
    would_support:
    - pathophysiology#Neonatal Neuronal Hyperexcitability

- discussion_id: gap_bfns_mouse_model_self_limiting_fidelity
  prompt: >-
    Why do earlier homozygous Kcnq2/Kcnq3 knock-in models show seizures
    persisting into adulthood while a newer Kcnq2-SeLNE model shows timely
    excitability recovery, and which allele, dosage, and developmental context
    best models the self-limited human course?
  kind: HUMAN_MODEL_MISMATCH
  status: OPEN
  attaches_to:
  - pathophysiology#Kv7.2/Kv7.3 M-Channel Dysfunction
  - pathophysiology#Loss of M-Current Control of Neuronal Excitability
  - pathophysiology#Neonatal Neuronal Hyperexcitability
  rationale: >-
    Earlier knock-in mice carrying human BFNC variants reproduce reduced
    M-current and lower seizure thresholds, but homozygous animals have
    recurrent seizures into adulthood. A newer phenotypic Kcnq2-SeLNE model
    instead shows timely recovery of neuronal excitability. This discrepancy
    may reflect allele, zygosity, background, brain region, or outcome
    definition and prevents treating either mouse time course as a direct
    surrogate for human remission.
  evidence:
  - reference: PMID:18483067
    reference_title: "Mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions show seizures and neuronal plasticity without synaptic reorganization."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Both Kcnq2(A306T/A306T) and Kcnq3(G311V/G311V) homozygous mutant mice exhibited early onset spontaneous generalized tonic-clonic seizures concurrent with a significant reduction in amplitude and increased deactivation kinetics of the neuronal M-current."
    explanation: >-
      The mouse model recapitulates the M-current defect and produces seizures,
      but with a course that diverges from the human self-limiting phenotype,
      defining the model-mismatch question.
  - reference: PMID:41051877
    reference_title: Delayed excitability recovery and downregulation of neurodevelopmental pathways contribute to phenotypic differences in KCNQ2-related disorders.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Notably, whereas SeLNE mice showed timely recovery of excitability, DEE mice displayed delayed restoration of abnormal excitability in CA1 excitatory neurons."
    explanation: >-
      The newer paired model reproduces an age-limited recovery trajectory,
      creating a direct contrast with the persistent-seizure homozygous models.
  proposed_experiments:
  - experiment_id: exp_bfns_human_ipsc_remission_readout
    name: Human iPSC cortical-organoid remission-window experiment
    description: >-
      Generate patient-derived and isogenic-corrected human cortical organoids
      carrying benign-familial-neonatal-seizure KCNQ2/KCNQ3 variants and track
      M-current, network excitability, and its maturational normalization over
      extended culture, comparing the trajectory against the persistent-seizure
      mouse phenotype.
    experiment_type:
      preferred_term: isogenic cortical organoid network-maturation experiment
    model_systems:
    - name: BFNS human iPSC-derived cortical organoid
      description: >-
        Human cortical organoid carrying benign-familial-neonatal-seizure
        KCNQ2/KCNQ3 variants, used for M-current and network-maturation readouts.
      experimental_model_type: ORGANOID
      namo_type: namo:Organoid
      organism:
        preferred_term: human
        term:
          id: NCBITaxon:9606
          label: Homo sapiens
      tissue_term:
        preferred_term: cerebral cortex
        term:
          id: UBERON:0000956
          label: cerebral cortex
      cell_types:
      - preferred_term: cortical neuron
        term:
          id: CL:0000540
          label: neuron
      - preferred_term: neural progenitor cell
        term:
          id: CL:0011020
          label: neural progenitor cell
      conditions:
      - benign familial neonatal seizures
      - neonatal neuronal hyperexcitability
      cell_source: Patient-derived or CRISPR-engineered human induced pluripotent stem cells
      culture_system: Three-dimensional cortical organoid with longitudinal network-activity assays
    perturbations:
    - name: KCNQ2/KCNQ3 variant correction or knock-in
      target: pathophysiology#Kv7.2/Kv7.3 M-Channel Dysfunction
      genes:
      - preferred_term: KCNQ2
        term:
          id: hgnc:6296
          label: KCNQ2
      - preferred_term: KCNQ3
        term:
          id: hgnc:6297
          label: KCNQ3
      description: >-
        Correct or introduce benign-familial-neonatal-seizure variants in an
        isogenic human iPSC background to compare M-current and network
        maturation.
    readouts:
    - name: M-current and network-maturation trajectory
      target: pathophysiology#Neonatal Neuronal Hyperexcitability
      biological_processes:
      - preferred_term: membrane repolarization
        term:
          id: GO:0086009
          label: membrane repolarization
        modifier: DECREASED
      assays:
      - preferred_term: patch-clamp electrophysiology assay
      - preferred_term: multielectrode array recording
      direction: POSITIVE
    controls:
    - name: Isogenic corrected organoids
      description: Matched organoids in which the variant is corrected.
    - name: Persistent-seizure mouse comparison
      description: Kcnq2/Kcnq3 knock-in mouse phenotype as the divergent model reference.
    decision_criterion: >-
      Human fidelity of the self-limiting course is supported if human organoid
      network hyperexcitability normalizes over maturation despite persistent
      mutant-channel expression, diverging from the persistent-seizure mouse
      trajectory.
    would_support:
    - pathophysiology#Kv7.2/Kv7.3 M-Channel Dysfunction
    - pathophysiology#Loss of M-Current Control of Neuronal Excitability
    - pathophysiology#Neonatal Neuronal Hyperexcitability
review_notes: >-
  The current ILAE term is self-limited (familial) neonatal epilepsy; BFNS and
  BFNC are retained as historical synonyms. The entry separates the mild
  syndrome from KCNQ2-DEE using course, development, neurologic examination,
  EEG background, and cautious variant-topology associations. Phenotype-table
  evidence on pathophysiology-to-phenotype edges anchors the observed
  manifestation, while M-current studies anchor the upstream mechanism.
  Carbamazepine and other sodium-channel-blocker evidence is retrospective and
  should not be read as randomized superiority or proven developmental benefit.
  NCT05157737 and the PMID:41988220 dataset span the broader KCNQ2 spectrum and
  require phenotype-stratified interpretation; trial status was unknown when
  checked on 2026-07-23. A D2P audit also surfaced low-frequency Orphanet
  annotations (gastroesophageal reflux, axial hypotonia, facial tics, simple
  febrile seizures, increased theta activity, and status epilepticus) plus
  OMIM-derived developmental findings. They were not promoted to canonical
  phenotypes here because primary-source context is absent or the finding may
  reflect the broader KCNQ2 spectrum rather than the self-limited boundary.
references:
- reference: ORPHA:1949
  title: "Self-limited neonatal epilepsy"
  findings: []
- reference: PMID:18483067
  title: "Mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions show seizures and neuronal plasticity without synaptic reorganization."
  findings: []
- reference: PMID:20437616
  title: "KCNQ2-Related Disorders."
  tags:
  - GeneReviews
  findings: []
- reference: PMID:22275249
  title: "KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy."
  findings: []
- reference: PMID:28926830
  title: "A Distinctive Ictal Amplitude-Integrated Electroencephalography Pattern in Newborns with Neonatal Epilepsy Associated with KCNQ2 Mutations."
  findings: []
- reference: PMID:36939707
  title: "ILAE Genetic Literacy Series: Self-limited familial epilepsy syndromes with onset in neonatal age and infancy."
  findings: []
- reference: PMID:36948217
  title: "KCNQ2-Related Epilepsy: Genotype-Phenotype Relationship with Tailored Antiseizure Medication (ASM)-A Systematic Review."
  findings: []
- reference: PMID:37827512
  title: "Distinctive Amplitude-Integrated EEG Ictal Pattern and Targeted Therapy with Carbamazepine in KCNQ2 and KCNQ3 Neonatal Epilepsy: A Case Series."
  findings: []
- reference: PMID:40236662
  title: "Oxcarbazepine may be an effective option for Chinese pediatric patients with self-limited focal epilepsy of neonatal/infantile onset: a retrospective cohort study."
  findings: []
- reference: PMID:41051877
  title: "Delayed excitability recovery and downregulation of neurodevelopmental pathways contribute to phenotypic differences in KCNQ2-related disorders."
  findings: []
- reference: PMID:41988220
  title: "KCNQ2 Variants in Neonatal Epilepsy: Clinical Characteristics and Neurodevelopmental Outcomes in 30 Patients."
  findings: []
- reference: PMID:42081271
  title: "KCNQ2 neonatal epilepsy: Impact of prompt diagnosis and treatment, and early predictors of outcome severity."
  findings: []
- reference: PMID:9425895
  title: "A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns."
  findings: []
- reference: PMID:9425900
  title: "A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family."
  findings: []
- reference: PMID:9836639
  title: "KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel."
  findings: []
- reference: clinicaltrials:NCT05157737
  title: "Clinical Phenotype and Omics Study of KCNQ2-related Epilepsy"
  findings: []
📚

References & Deep Research

References

16
ORPHA:1949
Self-limited neonatal epilepsy
No top-level findings curated for this source.
PMID:18483067
Mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions show seizures and neuronal plasticity without synaptic reorganization.
No top-level findings curated for this source.
PMID:20437616
KCNQ2-Related Disorders.
No top-level findings curated for this source.
PMID:22275249
KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy.
No top-level findings curated for this source.
PMID:28926830
A Distinctive Ictal Amplitude-Integrated Electroencephalography Pattern in Newborns with Neonatal Epilepsy Associated with KCNQ2 Mutations.
No top-level findings curated for this source.
PMID:36939707
ILAE Genetic Literacy Series: Self-limited familial epilepsy syndromes with onset in neonatal age and infancy.
No top-level findings curated for this source.
PMID:36948217
KCNQ2-Related Epilepsy: Genotype-Phenotype Relationship with Tailored Antiseizure Medication (ASM)-A Systematic Review.
No top-level findings curated for this source.
PMID:37827512
Distinctive Amplitude-Integrated EEG Ictal Pattern and Targeted Therapy with Carbamazepine in KCNQ2 and KCNQ3 Neonatal Epilepsy: A Case Series.
No top-level findings curated for this source.
PMID:40236662
Oxcarbazepine may be an effective option for Chinese pediatric patients with self-limited focal epilepsy of neonatal/infantile onset: a retrospective cohort study.
No top-level findings curated for this source.
PMID:41051877
Delayed excitability recovery and downregulation of neurodevelopmental pathways contribute to phenotypic differences in KCNQ2-related disorders.
No top-level findings curated for this source.
PMID:41988220
KCNQ2 Variants in Neonatal Epilepsy: Clinical Characteristics and Neurodevelopmental Outcomes in 30 Patients.
No top-level findings curated for this source.
PMID:42081271
KCNQ2 neonatal epilepsy: Impact of prompt diagnosis and treatment, and early predictors of outcome severity.
No top-level findings curated for this source.
PMID:9425895
A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns.
No top-level findings curated for this source.
PMID:9425900
A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family.
No top-level findings curated for this source.
PMID:9836639
KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel.
No top-level findings curated for this source.
clinicaltrials:NCT05157737
Clinical Phenotype and Omics Study of KCNQ2-related Epilepsy
No top-level findings curated for this source.

Deep Research

1
Manual Pubmed Review ▸
Benign Neonatal Seizures: Manual Deep Research Summary
n/a 6 citations 2026-05-13T13:30:00Z

Benign Neonatal Seizures: Manual Deep Research Summary

Disease-level modeling decision

Benign neonatal seizures is modeled as one disease-level entry covering the autosomal-dominant KCNQ2- and KCNQ3-related forms of self-limited familial neonatal epilepsy. Two molecular subtypes are exposed via has_subtypes, each grounded to the corresponding MONDO term:

  • KCNQ2-BFNS → MONDO:0007365 (seizures, benign familial neonatal, 1; xref OMIM:121200).
  • KCNQ3-BFNS → MONDO:0007366 (seizures, benign familial neonatal, 2; xref OMIM:121201).

The much more severe KCNQ2-related developmental and epileptic encephalopathy (KCNQ2-DEE) is intentionally excluded from this entry — the disease description notes the boundary so future curators do not collapse the two clinical entities.

Inheritance and penetrance

ORPHA:1949 lists autosomal dominant inheritance for self-limited neonatal epilepsy. The original KCNQ2 paper (PMID:9425895) frames the condition as "a dominantly inherited disorder of newborns."

The ILAE Genetic Literacy review (PMID:36939707) is the strongest source for incomplete penetrance and de novo inheritance:

"incomplete penetrance and de novo inheritance occur."

This justifies tagging both KCNQ2 and KCNQ3 Inheritance blocks in the genetic section with penetrance: INCOMPLETE.

Pathophysiology: KCNQ2/KCNQ3 LOF → M-current attenuation → transient neonatal hyperexcitability

The mechanistic chain is documented across the cached literature:

  1. KCNQ2 and KCNQ3 subunits form the neuronal M-channel. PMID:9836639: "It is concluded that both these subunits contribute to the native M-current."
  2. The M-current sets subthreshold excitability. PMID:9836639: "The M-current regulates the subthreshold electrical excitability of many neurons, determining their firing properties and responsiveness to synaptic input."
  3. Heterozygous LOF variants in KCNQ2/3 reduce M-current density and cause BFNC. PMID:9425895: "This finding in BFNC provides additional evidence that defects in potassium channels are involved in the mammalian epilepsy phenotype." PMID:9425900 maps a KCNQ3 pore-region missense variant co-segregating with BFNC.
  4. Network-level hyperexcitability is transient and remits. PMID:36939707: "Seizures tend to remit during infancy or early childhood and are therefore called 'self-limited'."

The disorder YAML therefore exposes two atomic pathophysiology nodes connected by a downstream edge:

  • KCNQ2/KCNQ3 K+ Channel Loss-of-Function and M-Current Attenuation (central_effector) — captures the molecular function (GO:0005249, DECREASED) and process (GO:0086009 membrane repolarization, DECREASED).
  • Neonatal Neuronal Hyperexcitability (downstream_phenotype) — captures the network-level firing increase (GO:0019228 neuronal action potential, INCREASED), localized to cerebral cortex, with a further downstream edge to the clinical Focal-onset Seizure phenotype.

This decomposition deliberately avoids the bundled "channelopathy → seizures" anti-pattern flagged in prior dismech reviews.

Clinical phenotypes

ORPHA:1949 supplies a curated HPO-frequency table that I have mapped directly into the phenotypes block:

  • Neonatal seizure (HP:0032807) — Very frequent (99–80%)
  • Focal-onset seizure (HP:0007359) — Very frequent
  • Focal tonic seizure (HP:0011167) — Very frequent
  • Focal clonic seizure (HP:0002266) — Very frequent
  • Apnea (HP:0002104) — Frequent (79–30%)
  • Focal EEG discharges with secondary generalization (HP:0011188) — Very frequent

PMID:28926830 (the multicenter aEEG case series) supports the focal tonic semiology with characteristic apnea and desaturation.

Diagnosis and targeted therapy

PMID:36939707 supports molecular genetic testing (MAXO:0000533) as part of the diagnostic workup. PMID:28926830 and PMID:37827512 jointly support amplitude-integrated EEG (aEEG) as an early-recognition tool that enables targeted carbamazepine therapy before genetic confirmation:

"Recognition of the distinctive ictal aEEG pattern in the NICU allowed early and effective targeted therapy with CBZ in four neonates, well before genetic results became available." (PMID:37827512)

Carbamazepine (CHEBI:3387) is exposed as a specific treatment using the treatment_term = MAXO:0000167 (anticonvulsant agent therapy) + therapeutic_agent = CHEBI:3387 pattern, with a target_mechanisms link back to the Neonatal Neuronal Hyperexcitability node. The Sodium-channel-blocking Antiseizure Medication Therapy treatment generalizes this to the drug class.

Phenobarbital is recognized in clinical practice as an empiric first-line neonatal antiseizure agent before genetic confirmation, but is intentionally not modeled as a targeted therapy because it does not act on the KCNQ2/3 mechanism; the YAML keeps the mechanistic focus on sodium-channel blockers, per the precision- medicine framing in PMID:28926830.

References used

  • PMID:9425895 — KCNQ2 discovery in BFNC.
  • PMID:9425900 — KCNQ3 pore-region missense in BFNC.
  • PMID:9836639 — KCNQ2/KCNQ3 as molecular correlates of the M-channel.
  • PMID:28926830 — Distinctive ictal aEEG pattern in KCNQ2 neonatal epilepsy; precision medicine with Na+-channel blockers.
  • PMID:36939707 — ILAE Genetic Literacy review of self-limited familial neonatal/infantile epilepsies; incomplete penetrance and de novo inheritance.
  • PMID:37827512 — Carbamazepine targeted therapy guided by aEEG pattern recognition.
  • ORPHA:1949 — Orphanet structured-database record (HPO frequencies, gene-disease table, MONDO/OMIM cross-references, inheritance).